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Abstract
Sugars, such as sucrose or invert sugar, have been used as tobacco ingredients in American-blend cigarettes to replenish 
the sugars lost during curing of the Burley component of the blended tobacco in order to maintain a balanced flavor. 
Chemical-analytical studies of the mainstream smoke of research cigarettes with various sugar application levels 
revealed that most of the smoke constituents determined did not show any sugar-related changes in yields (per mg 
nicotine), while ten constituents were found to either increase (formaldehyde, acrolein, 2-butanone, isoprene, benzene, 
toluene, benzo[k]fluoranthene) or decrease (4-aminobiphenyl, N-nitrosodimethylamine, N-nitrosonornicotine) in 
a statistically significant manner with increasing sugar application levels. Such constituent yields were modeled 
into constituent uptake distributions using simulations of nicotine uptake distributions generated on the basis of 
published nicotine biomonitoring data, which were multiplied by the constituent/nicotine ratios determined in the 
current analysis. These simulations revealed extensive overlaps for the constituent uptake distributions with and 
without sugar application. Moreover, the differences in smoke composition did not lead to relevant changes in the 
activity in in vitro or in vivo assays. The potential impact of using sugars as tobacco ingredients was further assessed 
in an indirect manner by comparing published data from markets with predominantly American-blend or Virginia-
type (no added sugars) cigarettes. No relevant difference was found between these markets for smoking prevalence, 
intensity, some markers of dependence, nicotine uptake, or mortality from smoking-related lung cancer and chronic 
obstructive pulmonary disease. In conclusion, thorough examination of the data available suggests that the use of 
sugars as ingredients in cigarette tobacco does not increase the inherent risk and harm of cigarette smoking.
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1.  Introduction
Cigarette  smoking  has  been  established  as  addictive 
and the cause of various diseases, such as cancer, car-
diovascular disease, and chronic obstructive pulmonary 
disease (COPD)� However, little is known about the eti-
ology of these diseases in terms of smoke composition 
and whether cigarette design characteristics or the use 
of ingredients might influence this composition� Because 
of the disease burden related to smoking, an improved 
understanding of such potential influences is of major 
toxicological and public health relevance� Such under-
standing may eventually support both the development 
of potentially less risky tobacco products (US Institute of 
Medicine, 2001) and of meaningful regulation�
Regulatory schemes for tobacco have been developing 
in various regions of the world over the past several years 
(World  Health  Organization  Study  Group  on  Tobacco 
Product Regulation, 2008), which also address the use of 
ingredients� To date, ingredients have been regulated in 
some countries by positive and negative lists (e�g� German 
Federal Ministry for Youth Family and Health, 1977; UK 
Department  of  Health,  2003),  which  would  suggest  a 
safe use of those listed as permitted� Nevertheless, this 
assumption has been questioned for certain ingredients 
(Talhout et al�, 2006; Rabinoff et al�, 2007), and in Canada, 
the use of many ingredients to tobacco including sugars 
was recently prohibited (Parliament of Canada, 2009)� 
Apart from the regulatory status, investigations have been 
conducted in recent years in order to assess the potential 
risk (per cigarette) or harm (for a population), which might 
stem from the use of ingredients in addition to the inher-
ent risk or harm from smoking tobacco manufactured 
into a cigarette (e�g� Carmines, 2002; Baker et al�, 2004a)� 
Data from individual toxicological studies performed by 
the tobacco industry have been submitted according to 
regulatory requirements (e�g� European Parliament and 
Council of the European Union, 2001, which is request-
ing all available toxicological study data)� For a few ingre-
dients, scientific assessments of the potential additional 
harm resulting of their use as cigarette ingredients were 
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published (Talhout et al�, 2006; Werley et al�, 2006; Heck, 
2010)� In the current context, the term “harm” refers to 
a population-based risk and includes the potential that 
the use of ingredients may facilitate initiation, impede 
cessation, or increase the intensity of use, which in more 
recent guidance documents has been referred to as “indi-
rect harm” (US Food and Drug Administration Center for 
Tobacco Products, 2011)�
In  the  Western  world,  there  are  two  major  types 
of  cigarettes  that  differ  in  their  tobacco  blending  and 
ingredient  content�  Virginia-type  cigarettes  are  mainly 
made  from  Virginia  (or  Bright)  tobacco�  In  the  blend 
preparation of American-blend cigarettes, a significant 
portion of the Virginia tobacco is replaced by air-cured 
tobaccos  (usually  Burley)�  Virginia  tobacco  is  high  in 
endogenous sugars, while cured Burley leaf is practically 
devoid  of  endogenous  sugars  due  to  catabolic  break-
down during curing (Fisher, 1999; Leffingwell, 1999)� A 
sensorially satisfactory adjustment of the total blend is 
achieved by applying a sugar casing to the tobacco blend 
of American-blend cigarettes, which in part replenishes 
the sugar content of the tobacco lost during Burley curing 
to a level that is generally below that found in Virginia-
type cigarettes in order to rebalance the sugar/nitrogen 
ratio of cured Burley tobacco and to enhance the taste 
and  smoke  characteristics  of  the  blend  (Fisher,  1999)� 
Thus, the use of sugars as tobacco ingredients is con-
sidered essential for an American-blend cigarette� The 
sugars used most widely as casing materials for tobacco 
are sucrose and invert sugar (the hydrolysis product of 
sucrose, mainly glucose and fructose)� Both are approved 
for use in tobacco products as additives, flavorings, or 
flavoring agents in all countries that have a list of ingredi-
ents that are allowed to be added to tobacco� For example 
in Germany, food-grade sugars are generally allowed as 
additives to tobacco (German Federal Ministry for Youth 
Family and Health, 1977); in the UK, invert sugar and 
sucrose can each be added to a maximum of 10% of the 
weight of tobacco plus paper, with an aggregate limit of 
15% of those additives typically used at higher applica-
tion levels (List 1, UK Department of Health, 2003)�
Because  of  the  importance  of  sugars  as  tobacco 
ingredients in American-blend cigarettes, many experi-
mental studies have been performed to date in order to 
better understand any potential toxicological impact of 
such use� This review evaluates the available informa-
tion  from  published  or  non-published  studies  based 
on searches in Medline and the documents of different 
cigarette manufacturers gathered in the Legacy Tobacco 
Document Library (http://legacy�library�ucsf�edu/)� The 
information discussed extends that in a previous review 
on  the  impact  of  using  sugars  as  ingredients  (Talhout 
et al�, 2006), e�g� by including in vitro and in vivo studies 
on the impact of sugars added as tobacco ingredients in 
research cigarettes or by evaluating their potential impact 
in commercial cigarettes, such as on smoking behavior� 
The overall objective for this assessment is to evaluate on 
a weight-of-evidence basis whether the use of sugars as 
tobacco ingredients increases the known risk and harm, 
which is inherent to tobacco smoking, or whether new 
risks are generated� After a short description of the meth-
odological approach used for this assessment, this review 
includes information on
– technical data on the use of sugars as ingredients in 
cigarette tobacco,
– the fate of sugars during the manufacturing process 
of cigarettes,
– the  unchanged  transfer  of  sugars  to  mainstream 
smoke and their potential direct physiological and 
toxicological effects,
– the degradation during pyrolysis or during burning 
in the cigarette matrix,
– the analysis of the chemical composition of the main-
stream smoke of research cigarettes with or without 
the application of sugars to tobacco,
– the toxicity of the smoke of such research cigarettes 
in in vitro and in vivo assays, and,
– a  comparison  of  smoke  composition,  smoking 
behavior and exposure, as well as disease risk data 
from predominantly American-blend and Virginia-
type  cigarette  markets  to  provide  an  indication  of 
potential  differences  in  the  harm  stemming  from 
these major types of commercial cigarettes with prin-
ciple differences in their content of ingredients, such 
as sugars�
2.  Methodological approach
2.1  Guidance for toxicological assessment of  
cigarette ingredients
A generally accepted regulatory guidance for the assess-
ment of existing or new cigarette ingredients is not avail-
able� However, various individual guidance documents 
and  recommendations  were  published  over  the  last 
several years (Dempsey et al�, 2011)� The US Institute of 
Medicine described some regulatory principles, which 
include  the  use  of  appropriate  toxicological  testing 
methods “with the objective of identifying those ingredi-
ents that add no significant toxicity to tobacco products 
and therefore can be considered safe in the context of 
this use” (US Institute of Medicine, 2001)� In the UK, a 
voluntary agreement suggested that apart from studies 
on transfer and pyrolytic degradation of an ingredient, 
a  toxicological  assessment  of  new  ingredients  should 
include in vitro genotoxicity and subchronic inhalation 
studies, preferentially in the cigarette matrix (Tobacco 
Manufacturers Association & UK Department of Health, 
1997)� In Germany, a guidance document was published 
suggesting the comparative and quantitative testing of 
ingredients in research cigarettes with and without the 
ingredient, which may include a series of in vitro tests 
that  may  be  supplemented  by  chemical  analyses  and   
in vivo testing (Deutsches Institut für Normung – Working 
Group Toxicology of Additives, 2004; Hahn and Schaub, 
2010)�  The  most  encompassing  recommendation  was Sugars as cigarette ingredients  247
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published  by  the  Life  Science  Research  Office,  which 
evaluated the feasibility of testing and laid out scientific 
criteria for the evaluation of ingredients added to tobacco 
(Life  Sciences  Research  Office,  2004a,b)�  The  above-
mentioned guidance documents assume the feasibility 
and relevance of a toxicological evaluation of ingredients 
as a design principle, i�e� the evaluation of an ingredient 
for use in cigarette tobacco in general without the need to 
be repeated for each particular brand in which this ingre-
dient is used� However, the World Health Organization 
study group on Tobacco Regulation concluded that the 
existing science base would currently not be sufficient to 
allow regulation based on design characteristics (Burns 
et al�, 2008; World Health Organization Study Group on 
Tobacco Product Regulation, 2008)� Rather, this group 
felt that a more robust tool might be the regulation of the 
smoke composition of commercial products (brands)�
This review attempts to consider both of these general 
positions with the intention of considering all available 
information:  sucrose  and  invert  sugar  were  evaluated 
as  neat  compounds  as  well  as  in  research  cigarettes 
with or without sugars applied as single ingredient or in 
combinations  of  ingredients�  In  addition,  commercial 
American-blend and Virginia-type cigarettes were com-
pared, which apart from some other factors significantly 
differ by the use of sugars and other ingredients�
2.2.  Challenges for comparative testing of  
ingredients in a cigarette matrix
Ingredient  mixtures  differ  between  brands  and  even 
within a given brand because of country-specific pref-
erences� Because of practical reasons and in line with 
the practice in other industries (e�g� for food additives: 
European Commission Health and Consumer Protection 
Directorate-General,  2001),  ingredients  have  usually 
been evaluated as design principles rather than repeat-
edly  for  each  product�  For  principle-based  testing, 
ingredients may be applied to research cigarettes, either 
individually or in combination, in a manufacturing pro-
cess which corresponds to that of commercial cigarettes� 
Several levels of ingredient application are required to 
allow  the  determination  of  potential  “dose-response” 
relationships� The use of a combination of ingredients 
includes the investigation of any potential interactions 
among the ingredients, while the use of single ingredi-
ents allows greater exaggeration of the application levels 
of the particular ingredient beyond use levels found in 
commercial cigarettes� Such exaggeration may improve 
the  potential  to  detect  any  adverse  effects  associated 
with the application of this ingredient, although it has 
its limits for the testing of ingredients at high unusual 
application levels if significant changes in the burning 
characteristics of the cigarette would occur which cannot 
be back-extrapolated to the ingredient levels in actual 
products� Both types of studies using single or combined 
ingredients were included in this review�
Cigarettes may be smoked in many ways by varying 
puffing  parameters,  such  as  puff  duration  or  volume, 
which  will  change  the  composition  of  the  resulting 
smoke  in  quantitative  terms�  For  toxicological  testing 
purposes, fixed machine-smoking conditions need to be 
maintained in comparative assessments to ensure com-
parative smoke generation conditions for testing (Burns 
et al�, 2008; World Health Organization Study Group on 
Tobacco Product Regulation, 2008)� The fixed smoking 
conditions are not considered to be representative of a 
human smoker or a group of smokers� While very intense 
machine-smoking conditions have been recommended 
for future tests for maximum yield (Burns et al�, 2008), this 
may be disadvantageous for the discriminatory power of 
chemical-analytical and toxicological tests (Roemer and 
Carchman, 2011)� Until now, most previous tests were 
conducted using smoking conditions in line with FTC (US 
Federal Trade Commission, 1967) or ISO (International 
Organization for Standardization, 2000) conditions using 
puffs of 35 ml taken over 2 s, once per minute� The appro-
priateness of this protocol versus a more intense smok-
ing condition was evaluated in the current assessment in 
terms of potential ingredient-related changes in smoke 
composition�
Various approaches to compare the results of a series 
of research cigarettes or cigarette brands were used in the 
past, depending on the objectives of the particular studies� 
For instance, precursor-constituent relationships may best 
be evaluated on the basis of total particulate matter (TPM), 
tar (TPM minus water and nicotine), or carbon monoxide 
yields� For chemical-analytical investigations and related 
risk  extrapolations,  nicotine  has  been  suggested  as  the 
reference smoke constituent for comparative evaluations 
(Burns et al�, 2008; World Health Organization Study Group 
on  Tobacco  Product  Regulation,  2008)�  For  the  current 
assessment, nicotine was chosen as the basis for compari-
son in all chemical-analytical studies� It should be noted 
that  the  research  cigarettes  in  this  type  of  comparative 
studies were generally made to the same cigarette weight 
by replacing tobacco with the ingredients to be tested� This 
can be considered worst case for the evaluation of poten-
tial effects of ingredients, because the cigarette nicotine 
content and thus the smoke yield of nicotine as the basis 
of the comparison automatically decreases with increasing 
ingredient applications levels� This is particularly relevant 
for  the  exaggerated  application  levels  in  some  research 
cigarettes� For the comparison of the results of in vitro and 
in vivo studies, TPM was used as the basis of comparison in 
the current assessment, because TPM was the lead param-
eter for dosing in these studies� Besides, as for nicotine, 
using TPM as a basis of comparison rather than comparing 
on a per cigarette basis offers a comparison of the qual-
ity rather than the quantity of smoke used� As most of the 
presented in vitro and in vivo studies were carried out with 
experimental or even standard reference cigarettes of quite 
similar design, a relatively constant TPM/nicotine ratio can 
be assumed for data transformation�
As  there  is  no  authoritative  recommendation  for 
the toxicological hazard assessment of cigarette ingre-
dients,  toxicological  test  systems  available  for  other 248  E. Roemer et al.
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regulatory environments, such as for pharmaceutical (e�g� 
International  Conference  on  Harmonisation,  1997)  or 
chemical (e�g� Organization for Economic Co-operation 
and Development, 2009) compounds, had to be selected 
and adapted to a comparative testing paradigm for ciga-
rette ingredients� In most of the assays selected, cigarette 
smoke is inherently active, which requires testing pro-
tocols suitable to achieve a discriminatory power that is 
needed to detect potential incremental changes in activ-
ity by modifications in the research cigarettes, such as 
increasing levels of ingredients� In addition to biological 
testing and in view of the complexity of the smoke aerosol 
compared to, e�g�, a pharmaceutical compound, rather 
comprehensive chemical analyses of potential changes in 
smoke composition by the use of ingredients have been 
conducted� Thus, assessing the toxicity of cigarette smoke 
requires both chemical analyses and biological assays for 
the intended comparative hazard assessment� Chemical 
analyses  relatively  precisely  determine  increases  and 
decreases in mainstream smoke yields of defined constit-
uents� However, predicting the impact of these increases 
and decreases on the overall toxicity of cigarette smoke 
is a major challenge� Biological assays are rather unspe-
cific  regarding  the  constituents  that  cause  a  response 
and  include  the  assessment  of  potential  biological 
interactions  among  constituents�  Therefore,  chemical 
and biological assays complement one another� In the 
current assessment, the results of chemical, in vitro, and   
in vivo studies were pooled for each endpoint investi-
gated  attempting  to  derive  quantitative  results  across 
studies dependent on the level of sugars applied�
Using  the  assumption  of  proportional  constituent/
nicotine uptake ratios, the hypothetical uptake of smoke 
constituents  from  research  cigarettes  with  or  without 
applied sugars in a given population was modeled on 
the basis of known uptake distributions for nicotine� This 
should allow an evaluation of the potential impact of a 
change in the uptake of a given smoke constituent due 
to changes in smoke composition triggered by the use 
of sugars as ingredients vis-à-vis the broad variability of 
uptake of this constituent in a population of smokers�
Exposure  studies  to  determine  whether  the  use  of 
ingredients may change smoking behavior have not been 
performed, except for menthol (reviewed by Heck, 2010)� 
Approaches for controlled clinical studies to address the 
potential impact of flavor ingredients on exposure were 
suggested  (Life  Sciences  Research  Office,  2004b),  but 
have not been validated for general use to our knowledge� 
Instead, the current analysis includes a comparison of 
published data on smoking behavior parameters, such as 
smoking prevalence or nicotine uptake, in major markets 
of American-blend or Virginia-type cigarettes, which dif-
fer, among other factors, in their sugar content�
For a complex mixture that causes complex pathogen-
eses, there is no unique and simple approach to combine 
all information available for a final conclusion� Rather, 
various layers of evaluation that weigh the respective evi-
dence need to be combined in a tiered approach�
3.  Fate of natural tobacco sugars and  
use of sugars as tobacco ingredients
Since tobacco is a natural plant product, it contains high lev-
els of carbohydrates, and sugars in particular (Fisher, 1999; 
Leffingwell, 1999)� Green tobacco leaves require a drying 
step (curing) before use as a cigarette filler, which critically 
influences the sugar content of the end product� The first 
curing step common for all tobacco types is the “yellowing 
stage,” which is the color change that results from chloro-
phyll degradation that starts as soon as the green leaves 
start  to  dry�  Enzymatic  hydrolysis  of  starch  into  sugars 
begins in the early stages of curing, and proteins begin to 
fragment, releasing amino acids� After the yellowing phase, 
different  curing  conditions  are  used,  depending  on  the 
variety of tobacco� Air-curing of Burley tobacco, which is 
grown using relatively high nitrogen fertilization and thus 
rich in nitrate, proteins, and amino acids, is performed by 
naturally drying the leaves at ambient temperature� This 
is a slow process that can last up to ten weeks� During this 
process,  enzyme  systems  in  the  leaf  remain  active  and 
sugars are catabolically consumed� As a result, the cured 
Burley leaves have very low (0�2%, Leffingwell, 1999) to not 
detectable (Fisher, 1999) sugar contents� In contrast, during 
flue-curing of Virginia tobacco used for Virginia-type ciga-
rettes, the yellowing is followed by a relatively short (about 
4  days)  drying  stage  under  controlled  humidity  and  at 
elevated temperatures, which stops enzymatic processes, 
such as sugar catabolism, due to desiccative dehydration 
but allows the degradation of starch to even increase the 
natural sugar content in the cured leaf� Residual sugar levels 
of 8–30% have been reported in flue-cured tobacco (Fisher, 
1999)� Virginia tobacco is also low in nitrogen-containing 
compounds, because of cultivar selection and the limited 
requirement for nitrogen fertilization� The sun-curing of 
Oriental tobacco does not involve controlling air tempera-
ture or humidity, but it is fairly similar to flue-curing in that 
the enzymatic processes are much more rapidly stopped 
than in air-curing� The natural sugar content of Oriental 
tobacco is intermediate (10–20%)�
The core blend components in American-blend filler 
consist of approximately 50% Virginia, 30% Burley, and 
20% Oriental (assuming proportional contributions from 
expanded and reconstituted materials to either tobacco 
type) according to the composition of the 2R4F reference 
research cigarette provided by the University of Kentucky 
(Chambers, 2003), which was designed to be representa-
tive for the American-blend markets (Chepiga et al�, 2000; 
Roemer et al�, 2004; Patskan et al�, 2008)� These tobaccos 
are of different grades, origins and crop-years� Virginia-
type cigarettes mainly consist of Virginia tobacco (includ-
ing expanded and reconstituted materials) with little or 
no Oriental tobacco� Thus, in American-blend cigarettes, 
a substantial part of the Virginia tobacco is replaced by 
Burley  (and  Oriental),  which  accordingly  reduces  the 
natural  sugar  content  of  the  blend�  This  loss  is  partly 
replenished by applying sugars as tobacco ingredients� 
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part of the manufacturing of the American-blend filler, in 
contrast to Virginia-type cigarettes� Generally, not more 
than 5% (w/w) of sugar is applied to American-blend 
cigarettes� This results in a similar or lower total sugar 
content in American-Blend compared to Virginia-type 
cigarettes� In the published literature, data on the actual 
sugar content in marketed cigarette tobacco can hardly 
be found, but the above theoretical calculation was con-
firmed by a comparison of American-blend and Virginia-
type cigarettes marketed in the UK reporting 11 and 16% 
total sugar content and 9 and 13% reducing sugar con-
tent, respectively (Woertz, 1983)� Average reducing sugar 
contents of 6�6 and 9�6% were reported for US American-
blend  and  Australian  Virginia-type  cigarette  brands, 
respectively (Scollo and Winstanley, 2008)�
The sugars most widely used as cigarette tobacco ingre-
dients are sucrose and invert sugar� Sucrose (table sugar, 
saccharose), one of the most widely distributed disaccha-
rides, is obtained commercially from sugarcane and beets� 
It is used in the granulated form, crystallized from the 
highest purity sugar liquor and, thus, is the highest-purity 
crystalline sugar product� Conversion (inversion) of the 
disaccharide sucrose into its two monosaccharide com-
ponents yields glucose and fructose� Invert sugar is the 
water-based mixture resulting from the almost complete 
inversion of sucrose (Figure 1)� Sugars suitable for human 
consumption  are  used  as  cigarette  tobacco  ingredients 
(generally recognized as safe (GRAS) for human oral con-
sumption: US Food and Drug Administration, 2000a,b)�
The only processing steps in the cigarette factory dur-
ing which sugars may further react are flue-cured tobacco 
expansion,  i�e�  increasing  the  volume  of  the  tobacco 
leaves, and Burley tobacco drying after casing, i�e� after 
the application of water soluble cigarette ingredients� The 
expansion process is performed at a very high tempera-
ture (ca� 350°C) under an inert atmosphere over a very 
short period of time (1–2 s)� A certain percentage of the 
flue-cured tobacco sugar contents is consumed during 
the process, depending on the conditions (Green et al�, 
2007)� The main products formed in the process appear to 
be sugar polymers and degradation products� Most vola-
tile and semi-volatile products that would be produced 
will be lost in the process depending on their volatility� 
Burley tobacco drying after casing is typically performed 
over 5–6 min, and the tobacco reaches a temperature of 
about 75°C at the end of the drying process (Abdallah, 
2004)� In fact, except for the much shorter heating time, 
Burley drying conditions are very similar to flue-curing 
conditions� Under these drying conditions, no change of 
the total sugars levels in the tobacco could be detected� 
The largest effect of the thermal treatment, besides water 
evaporation, is the release of ammonia� An increase in the 
levels  of  reaction  products  of  sugar-ammonia  reaction 
products was also reported (Moldoveanu et al�, 2011)�
Carbohydrates and nitrogen compounds in tobacco 
are important sources of flavor compounds in the smoke 
of tobacco blends (Noguchi et al�, 1971; Dickerson et al�, 
1976;  Leffingwell,  1976)�  Maillard  reactions  involving 
amino acids or ammonia and sugars are ubiquitous dur-
ing the curing, storing, processing, and particularly dur-
ing smoking of tobacco� Maillard reaction products are 
very diverse in chemical structure and flavoring poten-
tial� Many of them are heterocyclic compounds, a most 
important class being pyrazines� Caramelization refers 
to non-enzymatic browning reactions in which, unlike in 
the Maillard reactions, sugars do not react with amines� 
These reactions proceed through a complex series of oxi-
dation, dehydration, isomerization, and polymerization 
steps that are still poorly understood� Similar and addi-
tional amounts of the same flavor components found in 
the cured leaves are formed during smoking�
4.  Biological data related to  
transferred unchanged sugars
4.1.  Transfer of unchanged sugars to  
mainstream smoke
Carbohydrates  have  very  low  vapor  pressures  and  are 
characterized by thermal and oxidative lability at the tem-
peratures occurring in a burning cigarette (Baker et al�, 
2005)� Indeed, very small yields (about 0�5% [range 0�4–
0�8%]) of uniformly 14C-labeled glucose and sucrose were 
found to transfer unchanged from Burley tobacco into 
mainstream smoke (Gager et al�, 1971a), supporting the 
results of an earlier study (Kobashi and Sakaguchi, 1959)� 
Based on similarity in the structures of glucose, fructose 
and sucrose, it is expected by analogy that the unchanged 
transfer of fructose to smoke will be low as well�
If approximately 0�5% of the sugar added to cigarette 
tobacco  is  transferred  unchanged  to  smoke,  the  daily 
dose  of  sugar  from  smoking  would  be  approximately 
0�008 g per person per day under the worst case assump-
tions given in Table 1� This is negligible, e�g� in terms of 
caloric uptake, when compared with a daily dietary sugar 
Figure 1.  Chemical structures demonstrating the inversion of sucrose to glucose and fructose.250  E. Roemer et al.
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intake in Western countries in the order of 100 g per per-
son per day (Gibney et al�, 1995)�
4.2.  Absorption, distribution, and metabolism of 
sucrose, fructose, and glucose after inhalation
During smoking, minor unchanged portions of sucrose, 
glucose,  and  fructose  are  inhaled  and  exposed  to  the 
respiratory tract� Sucrose cannot be taken up or hydro-
lyzed in pulmonary epithelial cells (Ricard et al�, 2000)� 
If not cleared by mucociliary clearance, it passively leaks 
through the alveolar wall, distributes systemically, and 
is excreted unchanged in the urine (Martindale, 1993)� 
Glucose and fructose are taken up by respiratory tract tis-
sues and used for intermediary metabolism� In tracheal 
and  pulmonary  experimental  systems,  active  glucose 
uptake was demonstrated to be regulated by nutritional 
and hormonal mechanisms (Das et al�, 1985)� Glucose is 
actively removed from the airway lumen against a 10-fold 
higher  glucose  plasma  concentration  gradient  (Baker 
et  al�,  2006a)�  Since  no  such  physiological  regulation 
of fructose utilization in lungs has been observed, the 
uptake of fructose into alveolar epithelial cells is assumed 
to be by gradient-driven facilitated diffusion, similar to 
fructose uptake in intestinal epithelial cells�
4.3.  Physiological properties of sugars
Apart from the nutritional value, sugars exert the senso-
rial cue of a sweet taste on the tongue� The thresholds at 
which sweet tastes are recognized for sucrose, fructose, 
and glucose are relatively high, i�e� in the order of 10 g/l 
(Soldo et al�, 2003; Pasquet et al�, 2006), and these thresh-
olds do not seem to be influenced to a relevant degree by 
smoking (Mullings et al�, 2010)� If the entire amount of 
unchanged sugars taken up by smoking (Table 1) were 
to dissolve in the saliva (daily production 1–1�5 l, Thews 
et al�, 1989), this would result in a maximum average con-
centration of 0�01 g/l, which is three orders of magnitude 
below the threshold at which a sweet taste is detected� The 
volume of saliva covering the sensory area of the tongue 
at a given time would need to be as low as 20 µl in order to 
reach a level at which a sweet taste could be detected with 
the 0�2 mg of sugar absorbed from smoking one cigarette 
with added sugar, assuming full dissolution in the saliva 
and  no  transfer  to  lower  parts  of  the  respiratory  tract� 
Thus, it is unlikely that the sugar transferred unchanged to 
smoke would elicit a sweet taste sensation in the smoker� 
Since sweet taste sensation and palatability are necessary 
requirements of any central reward mechanism for sugars 
(Barbano and Cador, 2007; Olszewski and Levine, 2007), 
there is no practical possibility of the small amounts of 
unchanged sugars in smoke to contribute to the initiating 
and addicting potency of smoking, as was previously sug-
gested (Talhout et al�, 2006; Rabinoff et al�, 2007)�
The  above  rationale  renders  a  sweet  sensation  by 
unchanged sugars used as cigarette tobacco ingredients 
very unlikely� Nevertheless, the use of sugars positively 
adds to the overall sensory perception of tobacco smoke 
(Leffingwell, 1976; Fisher, 1999; Rodgman, 2002; Talhout 
et  al�,  2006)�  In  the  subjective  evaluation  of  cigarette 
smoke taste, trained panels have used the term “sweet” 
as a descriptor (Baker, 2007)� However, this is meant as 
a pleasant, mild, non-harsh quality, quite different from 
the taste quality of a sweet receptor sensation� It is unclear 
to what extent sugar-dependent changes in mainstream 
smoke composition might elicit responses at taste recep-
tors independent of the role of the parent ingredients�
4.4.  Toxicological properties of sugars
Sucrose and invert sugar are GRAS and can be used in food 
without limitation (US Food and Drug Administration, 
2000a,b)�  The  three  sugar  compounds  exert  in  vitro, 
acute, and chronic toxicities only at exaggerated expo-
sures  (American  Congress  of  Governmental  Industrial 
Hygienists, 1991)� A number of chronic diseases has been 
associated with sugar-related malnutrition (e�g� Basciano 
et al�, 2005; Michaud et al�, 2005)� Sugar-rich food, total 
sucrose intake, ratio of sucrose to dietary fiber, and gly-
cemic index were associated with an increased risk for 
lung  cancer  in  a  case-control  study  (De  Stefani  et  al�, 
1998), while in another study, no such relationship was 
seen (Burley, 1998)� Potential underlying mechanisms for 
the chronic diseases related to malnutrition- or disease-
related  sugar  imbalances  include  glucotoxicity,  which 
depends  on  the  shift  of  glucose  metabolism  from  the 
glycolytic pathway to minor forms of glucose metabolism, 
including increased oxidative stress (Federici and Lauro, 
2005), and the formation of advanced glycation end prod-
ucts from reducing sugars, such as fructose (Gaby, 2005)�
All of these effects, even those related to the respira-
tory  tract,  are  not  relevant  to  the  minute  sugar  uptake 
from  smoking�  Nevertheless,  the  uptake  of  sugars  via 
inhalation needs to be specifically assessed, as elevated 
glucose concentrations in the airway epithelial lining fluid 
have been associated with accelerated growth of pulmo-
nary  pathogens  and  pulmonary  inflammation  (Baker 
et al�, 2006a)� Occupational exposure to sucrose is only 
regulated based on its nuisance dust character at 5 mg/
m3 (US Occupational Safety and Health Administration, 
2010),  which  would  lead  to  a  daily  sucrose  uptake  of 
approximately 50 mg of sucrose, which is above the daily 
dose of sugars reaching the smoker’s respiratory tract if 
Table 1.  Estimate of ingredient sugar uptake (worst case 
assumptions) by smoking American-blend cigarettes.
Parameter Estimate
Number of cigarettes per day§ 40 cig.
Maximum use level for all sugar sources 5%
Tobacco weight 0.8 g/cig.
Transfer of unchanged sugars 0.5%
Bioavailability (deposition) 100%
Dose per cigarette 0.2 mg
Daily dose 8 mg
For risk extrapolations, worst case assumptions were made: 
sucrose, glucose, or fructose, respectively, used as if representing 
total sugar doses; local deposition on tongue or in lungs as if total 
dose would be deposed at either site.
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estimated under worst case conditions (Table 1)� Glucose 
levels in airway secretions are approximately one tenth of 
the blood glucose levels (Baker et al�, 2006a), i�e� at about 
100 mg/l� With an estimated volume of lung epithelial lin-
ing fluid of 30 ml (Rennard et al�, 1986), 0�2 mg of glucose 
stemming from smoking one cigarette would result in a 
local transient increase in concentration of 7 mg/l, i�e� an 
increase of 7% above baseline� This increase is within the 
physiological variation expected for epithelial lining fluid 
glucose levels due to diet-induced changes in blood and, 
therefore, would not be expected to increase the risk of local 
pulmonary adverse effects associated with hyperglycemia� 
Fructose levels in the epithelial lining fluid are similar to 
those in the blood, i�e� 10 mg/l (Gaby, 2005), since there is 
no active fructose transport in the lungs� Addition of 7 mg/l 
from smoking one cigarette, calculated under worst case 
assumptions, is in the same order of magnitude as the 
physiological fructose level in the epithelial lining fluid� 
Blood fructose levels can increase by fivefold or more after 
a higher dietary dose of fructose� Therefore, the estimated 
increase of pulmonary fructose from smoking is within the 
range of what can be expected by transiently increasing 
the blood fructose levels by dietary uptake�
Sugars have also been approved for use as excipients 
for pulmonary drug delivery, such as glucose or lactose 
in dry powder inhalers (Kohlhäufl et al�, 2004; Pilcer and 
Amighi,  2010)�  Lactose,  a  disaccharide  very  similar  in 
structure to sucrose, is well recognized as a safe pharma-
ceutical excipient for use in oral or inhalation formula-
tions and is also not likely to constitute any significant 
toxicological  hazard  to  man  (Baldrick  and  Bamford, 
1997)� The use of sugars as inhalation excipient supports 
the notion that the unchanged sugar that may be inhaled 
with smoking does not contribute any toxicity�
5.  The effect of sugars on mainstream  
smoke composition
The most straight-forward approach to address the effects 
of sugars used as ingredients on mainstream smoke com-
position is to investigate the overall composition of main-
stream smoke generated from research cigarettes with 
or without sugars applied to tobacco� Direct precursor-
product relationships, which may be potentially relevant 
for smoking, can be qualitatively addressed by pyrolyzing 
the ingredient as a neat compound or in combination with 
other tobacco constituents or tobacco itself� One way of 
studying quantitative precursor-product relationships in 
the tobacco matrix is the use of radiolabeled precursors� 
Further information can be obtained by comparing mar-
ket cigarettes that may or may not include the ingredient 
under investigation (vide infra)�
5.1.  Pyrolysis experiments with sugars
Direct ingredient-product relationships have been inves-
tigated in more or less controlled pyrolysis experiments 
of  variable  design,  mostly  in  the  absence  of  tobacco� 
Pyrolysis  is  the  breakdown  of  larger  compounds  to 
smaller ones caused by exposure to heat, sometimes in 
the presence of reactive gases such as oxygen� Pyrolytic 
products of tobacco constituents or ingredients can also 
form  compounds  that  have  molecular  weights  larger 
than the precursor by a process known as pyrosynthesis� 
In addition, when oxygen is present, oxidative reactions 
can occur such as combustion� During smoking, most 
tobacco is combusted to carbon dioxide and water or 
incompletely combusted to carbon monoxide or less oxi-
dized smoke constituents (Green and Rodgman, 1996)�
Glucose,  fructose,  sucrose  (Table  2,  Figure  2),  invert 
sugar,  and  also  cellulose  produce  essentially  the  same 
Table 2.  Compounds qualitatively identified in a sucrose 
pyrolysis experiment according to Figure 2.
Peak 
number Compound
1 Air
2 Carbon dioxide
3 Formaldehyde
4 Water
5 Acetaldehyde
6 Furan
7a Mixture of acrolein and
7b 2-propanol
8 Acetone
9 Pyruvaldehyde
10 2-methylfuran
11 2-butanone
12 3-buten-2-one
13 Diacetyl
14 Glycolaldehyde
15 2,5-dimethylfuran
16 Formic acid
17 Acetic acid
18 1-hydroxy-2-propanone
19 3-furanone
20 Furfural
21 2-furanmethanol
22 2-acetylfuran
23 2(3H)-dihydro-4-hydroxy-2-3(H)furanone
24 2-hydroxycyclopent-2-en-1-one
25 5-methyl-2-furfural
26 1,3-dihydroxy-2-propanone
27a Mixture of 2-hydroxy-3-methyl-2-cyclopenten-1-one and
27b furanone
28a Mixture of 2,5-dimethyl-4-hydroxy-3-(2H)furanone and
28b 2,4-hexanedione
29 Methylfuroate
30 5-methyl-1,3-benzenediol
31 2,3-dihydro-3,5-dihydroxy-4H-pyran-4-one
32 3,5-dihydroxy-2-methyl-4H-pyran-4-one
33 1,4:3,6-dianhydro-α-d-glucopyranose
34 5-(hydroxymethyl)-2-furfural
35 1,5-anhydro-4-deoxy-d-glycero-hex-1-en-3-ulose
36 An anhydro-sugar
37 Levoglucosan
38 1,6-anhydro-β-d-glucofuranose252  E. Roemer et al.
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compounds upon pyrolysis, and any differences observed 
in the pyrolysates of the carbohydrates are quantitative 
rather than qualitative (Sanders et al�, 2002; Baker et al�, 
2005)� This is an expected result given the close chemical 
and structural similarity of these carbohydrates� Different 
patterns of carbonyl compounds were found depending 
on the sugar type investigated (Baker et al�, 2005; Talhout 
et al�, 2006)� The pyrolysis products from the mono- and 
disaccharides are also products of the pyrolysis of tobacco 
itself, since tobacco contains approximately 10% of the 
polysaccharide cellulose (Leffingwell, 1999) and, except 
for  uncased  cured  Burley  tobacco,  high  concentrations 
of sugars as well (Sanders et al�, 2002; Baker et al�, 2005)� 
Major  pyrolysis  products  from  glucose,  fructose,  and 
sucrose are furans, including furfural and 5-hydroxymeth-
ylfurfural, as well as acetic acid and levoglucosan� Furfural 
yields were higher than those of formaldehyde in pyrolysis 
experiments�  Formaldehyde  predominately  stems  from 
the hydroxymethyl moiety of sugars� Pyrolysis of cellulose 
yields a greater percentage of low molecular weight ketones 
and aldehydes, such as acetaldehyde and hydroxyacetal-
dehyde, relative to glucose, fructose and sucrose (Sanders 
et al�, 2002)� Pyrolysis yields of acrolein from various sugar 
types are inconsistent, although acrolein does appear to 
be a pyrolysis product from sucrose as well as from mono-
saccharides  (Baker  et  al�,  2005)�  The  presence  of  other 
materials in such pyrolysis experiments, such as tobacco, 
ammonia compounds, or metal salts was shown to change 
the quantitative composition of the respective pyrolysates 
(Torikai et al�, 2005)� Carbonyl compounds stemming from 
the pyrolytic degradation of sugars may react with ammo-
nia compounds (Baker et al�, 2006b), and the pyrosynthetic 
formation of aromatic hydrocarbons was also described 
under certain conditions (Britt et al�, 2004)�
The  extrapolation  of  the  results  of  pyrolysis  model 
experiments to mainstream smoke chemistry is difficult 
because no model can completely replicate the complex 
chemical  and  physical  processes  that  occur  under  real-
life smoking conditions or even those that occur during 
machine-smoking� During smoking, the chemical trans-
formations that carbohydrates undergo are influenced by 
many factors, including time-dependent local temperature 
changes, the concentration profile of oxygen and other par-
ticipating substances at and behind the burning zone, and 
pyrosynthetic reactions involving two or more tobacco or 
smoke constituents� Thus, although pyrolysis experiments 
may provide qualitative information on potential reactions, 
more relevant information regarding the fate of sugar ingre-
dients in tobacco products and their reaction products dur-
ing smoking is obtained in cigarette-smoking experiments, 
i�e� in the right matrix and with standardized smoking and 
quantitative analytical protocols� Other authors concluded 
that the pyrolysis of the neat ingredient by itself is not suf-
ficient for assessment (Hahn and Schaub, 2010)�
5.2.  Pooled quantitative chemical analyses of 
research cigarettes with and without sugars applied as 
tobacco ingredients
Over the past several years, three publications appeared 
covering a series of chemical-analytical studies on the 
mainstream  smoke  composition  of  research  cigarettes 
with and without sugars applied as single tobacco ingre-
dients that reported the yields of a broad series of toxi-
cologically relevant constituents (Table 3) (Baker, 2006; 
Figure 2.  Total GC-MS ion current finger-print chromatogram obtained from the pyrolysis of sucrose in air. For compound identifications, 
see Table 2. The pyrolysis unit was programmed to 1000°C with a three-step temperature program (400, 700, and 1000°C) with a 10-s hold 
time at each temperature. Comparison to data published elsewhere (Baker et al., 2005) suggest that yields of pyrolysis products are in the 
order of 1 µg per mg sugar pyrolyzed in this type of experiment.Sugars as cigarette ingredients  253
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Table 3.  Regression analyses of individual and pooled chemical-analytical data on the relationship of mainstream smoke constituent 
yields (nicotine-based) and sugar addition levels in research cigarettes.
Constituent
Statistical significance of slopes and change at 5% application level based on linear regression
ISO data HCI data
Individual studies& Pooled studies Individual Pooled
1 2 3 4 5 6 7 8 Slope p value R2 Change§ 7–HCI 8–HCI Slope
Tar = = = = = = = = = 0.9491 – – = = =
Carbon monoxide = = = = =   = = = 0.1804 – – = = =
Formaldehyde = ↑ = ↑ ↑ ↑ = = ↑ 0.0005 0.24 25% = = ↑
Acetaldehyde = ↑ ↑ = = = = ↑ = 0.3826 – – = = =
Acrolein = ↑ = ↑ = ↑ = = ↑ 0.0009 0.22 10% ↑ = =
Propionaldehyde = = ↑ ↑ = ↑ = ↑ = 0.6376 – – ↑ = ↑
n-Butyraldehyde – – – – = = = ↑ = 0.5435 – – = = =
Crotonaldehyde – – – – = = = ↑ = 0.1022 – – = = =
Acetone – – – – ↑ = = ↑ = 0.1234 – – = = =
2-Butanone – – – – = ↑ = ↑ ↑ 0.0045 0.29 9% = = =
1,3-Butadiene = = = ↑ – – = ↑ = 0.6112 – – = = =
Isoprene = = = = – – = ↑ ↑ 0.0065 0.25 12% = = =
Acrylonitrile ↑ = = ↑ – – = = = 0.2444 – – = = =
Hydrogen cyanide = = ↑ ↑ – – = = = 0.6849 – – = = =
2-Nitropropane = = = = – – – – = 0.6466 – – – – –
4-Aminobiphenyl = = = = – – = = ↓ 0.0124 0.22 –21% = = =
o-Toluidine ↓ ↓ = = – – – – = 0.5124 – – – – –
2-Naphthylamine = = = = – – – – = 0.8311 – – – – –
o-Anisidine – – = = – – – – = 0.2250 – – – – –
Nitrogen oxides = = = = – – ↓ = = 0.5313 – – = = =
Benzene = ↑ ↑ ↑ – – = ↑ ↑ 0.0011 0.34 9% = = =
Toluene ↑ ↑ ↑ ↑ – – = ↑ ↑ <0.0001 0.51 9% = = =
Styrene – – – ↑ – – = = = 0.0039* – – = = ↑
N-Nitrosodimethylamine – – = ↑ – – – – ↓ 0.0003 0.74 –12% – – –
N-Nitrosopyrrolidine = = = ↓ – – – – = 0.0902 – – – – –
N-Nitrosonornicotine = = = ↓ – – ↓ = ↓ <0.0001* 0.69 –12% = = =
NNK = = = = – – = = = 0.4278* – – = = =
Phenol = =   ↓ – – = = = 0.4072 – – = = =
Catechol = = = = – – = = = 0.1749 – – = = =
Benzo[a]anthracene = = = = – – – – = 0.9136 – – – – –
Benzo[b]fluoranthene = = = ↑ – – – – = 0.6700 – – – – –
Benzo[j]fluoranthene – – = ↑ – – – – = 0.8542 – – – – –
Benzol[a]fluoranthene – – = ↑ – – – – ↑ 0.0044 0.57 7% – – –
Benzo[a]pyrene = = = ↑ – – = = = 0.2168 – – = = =
Indeno[1,2,3-cd] pyrene ↑ = = ↑ – – – – = 0.2400 – – – – –
Sugars used as ingredients in individual studies:
1: Sucrose (Coggins et al., 2011).
2: Invert sugar (Coggins et al., 2011).
3: Honey (Coggins et al., 2011).
4: High fructose corn syrup (Coggins et al., 2011).
5: White and brown sugar, invert sugar (Baker, 2006; test cigarettes D2 to D5, D8, and D10 vs. control cigarette D1).
6: Brown sugar, invert sugar, honey, glucose, fructose (Baker, 2006; test cigarettes E2 to E9, E11, and E13 vs. control cigarette E1).
7: Sucrose, research cigarettes yielding 6 mg ISO tar/cig., machine-smoked under ISO and HCI conditions (Roemer et al., 2010).
8: Sucrose, as in 7 but with research cigarettes yielding 10 mg ISO tar/cig. (Roemer et al., 2010).
↑, ↓:   Slopes of regression analysis (GraphPad software) statistically significantly different from zero (increase, decrease); = : slopes of 
regression analysis not statistically significantly different from zero; -: not done/not applicable; R2: regression coefficient.
§: Change at a usual maximum use level of 5% sugar addition relative to control without sugar use.
*:   Two different pools of data from different laboratories, lowest p value given.
ISO smoking conditions: puff volume, duration, and frequency of 35 ml, 2 s, and 1 min−1, respectively (International Organization for 
Standardization, 2000).
HCI (Health Canada intense) smoking conditions: puff volume, duration, and frequency of 55 ml, 2 s, and 2 min−1, respectively, and 
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Roemer et al�, 2010; Coggins et al�, 2011)� Various forms 
of sugars were investigated, including sucrose and invert 
sugar, but also white and brown sugar, glucose, fructose, 
high fructose corn syrup (HFCS), honey, and molasses� 
All of these studies used tobacco blends representative 
of American-blend cigarettes to produce research ciga-
rettes that were cased with various levels of the respective 
sugar ingredient� In most studies, the highest application 
levels exceeded the maximum application levels of sug-
ars in commercial cigarettes (for overview, see Talhout 
et al�, 2006) in order to improve the ability to detect dif-
ferences in the smoke composition or the toxicological 
activity of the research cigarettes with and without sugar 
application� The cigarettes were machine-smoked under 
ISO standard conditions (International Organization for 
Standardization, 2000), and, in one study, under Health 
Canada intense (HCI) conditions (Health Canada, 2000) 
in  parallel�  The  TPM  yields  for  the  research  cigarettes 
included in the current analysis varied between 6 and 
18 mg  per  cigarette  using  the  ISO  smoking  regimen, 
and  should  thus  address  much  of  the  variability  seen 
for marketed cigarettes� ISO nicotine yields varied from 
0�5 to 1�2 mg per cigarette� A set of more than 35 gener-
ally  accepted  and  toxicologically  relevant  smoke  con-
stituents was analyzed in these studies, which has been 
developed in similar compositions on the basis of the so-
called Hoffmann analytes (US Consumer Product Safety 
Commission, 1993; Health Canada, 2000)�
In order to obtain added statistical power by a larger 
sample size, the results of all relevant studies obtained 
under ISO smoking conditions were pooled for the indi-
vidual constituents, regardless of the sugar type examined 
in the particular studies� This was possible because of the 
similarity in cigarette construction, smoking conditions, 
and  analyses�  Molasses  was  excluded  from  this  pool 
because it was considered to contain significant concen-
trations of materials other than sugars� The pooled data 
were analyzed by linear regression as a function of the 
sugar application level, and the resulting slopes were sta-
tistically tested for difference from a zero slope (Table 3)� 
This approach should reduce the number of false positive 
statistical  results  from  the  several  hundred  individual 
statistical tests underlying this pool of data and should be 
more discriminative than the analysis of individual stud-
ies, if the inter-study variabilities are small� The approach 
of pooling the results obtained using different types of 
sugars was corroborated by the lack of differences seen in 
a direct comparison of the smoke composition generated 
from research cigarettes with corn syrup/invert sugar or, 
alternatively, high fructose corn syrup (Stavanja et al�, 
2006)�
On a nicotine basis, there was no effect by the sugar 
application  on  the  yields  of  the  leading  quantitative 
smoke  parameters  for  the  particulate  and  gas/vapor 
phases,  i�e�  tar  and  carbon  monoxide,  for  a  range  of 
application  levels  up  to  approximately  10%  (Table  3)� 
Under  ISO  smoking  conditions,  the  nicotine-based 
yields of most smoke constituents in the pooled analysis, 
such  as  those  of  acetaldehyde,  1,3-butadiene,  phenol, 
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone 
(NNK), or benzo[a]pyrene, did not change in a statistically 
significant manner with increasing sugar application lev-
els (Table 3)� However, the nicotine-based yields of seven 
constituents increased in a statistically significant man-
ner, i�e� formaldehyde, acrolein, 2-butanone, isoprene, 
benzene,  toluene,  and  benzo[k]fluoranthene,  while 
those of N-nitrosodimethylamine, N-nitrosonornicotine, 
and  4-aminobiphenyl  decreased�  These  results  are  in 
broad agreement with the model pyrolysis results, i�e� an 
increased yield in some carbonyl constituents and vice 
versa a decrease in some nitrogen-containing constitu-
ents, the precursors of which might have been trapped by 
the excess carbonyl compounds� No nitrogen-containing 
constituent increased in yield, which is also attributable 
to the replacement of nitrogen-containing tobacco mate-
rial with the carbohydrate ingredient� There is no ready 
explanation  why  one  of  the  three  benzo-fluoranthene 
isomers would increase but not the others� For benzo[a]
pyrene, used as a surrogate for the group ofpolycyclic 
aromatic hydrocarbons in many analyses, there was also 
no statistically significant change�
Under the more intense HCI machine-smoking con-
ditions,  most  of  the  above-discussed  differences  were 
no longer apparent (Table 3)� After pooling the results 
obtained with the two research cigarettes types, slopes 
with statistically significant increases were only seen for 
the nicotine-based yields of formaldehyde, propionalde-
hyde, and styrene (Table 3)� Most of the nicotine-based 
yields  obtained  under  HCI  conditions  fitted  well  with 
those obtained under ISO conditions (Figure 3), confirm-
ing the validity of the current results and the applicabil-
ity of the current interpretations to the broad spectrum 
of human smoking conditions� Only the nicotine-based 
formaldehyde yields seemed to be approximately 50% 
higher under HCI than under ISO conditions, but with 
a similar percentage of increase at 5% compared to 0% 
sugar application (Figure 3A)� Thus, the sugar applica-
tion-dependent effects observable under ISO machine-
smoking conditions tend to be less pronounced under 
more  intense  smoking  conditions,  which  is  probably 
due to more complete combustion during smoking� This 
is in line with the general observation of less difference 
among test results for various non-clinical tests of smoke 
for samples generated under intense versus ISO condi-
tions (Roemer and Carchman, 2011)�
5.2.1.  Formaldehyde
The  most  pronounced  change  with  increasing  sugar 
application levels in the pooled data were for formal-
dehyde (Figure 3A)� At a use level of 5%, this correlation 
reveals a maximum increase by 25% over the control with 
no added sugar� About a quarter of the observed varia-
tion in formaldehyde formation can be ascribed to the 
sugar  application  (R2,  Table  3)�  Further  variation  may 
be associated with potential differences in the series of 
research  cigarettes  used  in  the  individual  studies  and Sugars as cigarette ingredients  255
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with analytical variations both within and between the 
laboratories� Formaldehyde is also formed from tobacco 
matrix components, such as cellulose, and is higher in the 
first puff of mainstream smoke than in subsequent puffs 
(Parrish and Harward, 2000; Baker, 2006)� Correlations of 
formaldehyde with other smoke constituents may also 
be influenced by its reactivity with components of the 
tobacco rod and in the smoke (or in the sampling device)� 
The overall formaldehyde yield in commercial cigarettes 
is correlated with the respective tar yield at less intense 
but not at HCI machine-smoking conditions (data from 
Gregg et al�, 2004; Counts et al�, 2005; Hyodo et al�, 2007)�
The relationship of tobacco types and sugar and ammo-
nia  content  to  formaldehyde  yields  was  investigated 
in a puff-wise analysis of single-blended cigarettes, i�e� 
research cigarettes made from only one type of tobacco� 
Burley, Virginia, and Oriental tobaccos yielded 1�0, 3�9, 
and 7�7 µg of formaldehyde per puff, respectively, with 
corresponding reducing sugar contents in the tobaccos 
of 2�2, 8�3, and 15�9% (Parrish and Harward, 2000)� If the 
Virginia tobacco was expanded by carbon dioxide in the 
presence of ammonia, the formaldehyde yield dropped 
to 2�0 µg/puff, indicating that its yield depended both 
on the availability of sugars providing the carbonyl func-
tions and of nitrogen-containing components in tobacco 
or smoke scavenging these carbonyls� In an analytical 
study on the mainstream smoke of research cigarettes 
with various combinations of tobacco ingredients, form-
aldehyde was found to increase by 77% (nicotine-based) 
in  the  group  containing  corn  syrup  (at  6�3%)  among 
other  ingredients,  but  it  only  slightly  increased  in  the 
group containing invert sugar and sucrose (at a total of 
13%) in another combination (Rustemeier et al�, 2002), 
again  indicative  of  interactions  between  cigarette  or 
smoke components leading to non-proportional sugar-
formaldehyde  relationships�  Significantly  increased 
yields of formaldehyde (up to 88%, nicotine-based) were 
also observed with another series of ingredient mixtures 
Figure  3.  Yields  (nicotine-based)  of  formaldehyde  (A),  acetaldehyde  (B),  acrolein  (C),  benzene  (D),  N-nitrosonornicotine  (E),  and 
4-aminobiphenyl (F) in the mainstream smoke of research cigarettes of pooled studies with research cigarettes with varying sugar application 
levels. Linear regression (solid lines) with 95% confidence limits was performed on yield data obtained with ISO machine-smoking. For 
formaldehyde, an additional linear regression (dashed line) was derived for yield data obtained under HCI smoking conditions. The HCI 
data for the other constituents fit well to the set of ISO data. M ± SD for individual data points (SDs by non-weighted error propagation). 
The legend in graph C applies to all graphs in Figure 3; for study references, see Table 3.256  E. Roemer et al.
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with sugar application levels of up to 10�5% (Baker et al�, 
2004b)�
5.2.2.  Acetaldehyde
In the current pooled analysis, there was no statistically 
significant  effect  on  acetaldehyde  yields  with  increas-
ing sugar application levels (Figure 3B), although such 
increase was determined in three of the eight individual 
studies (Table 3)� There was also no sugar-related effect if 
research cigarettes were smoked under HCI conditions�
This overall lack of effect is consistent with the results 
of  a  previous  review  which  concluded  that  the  sug-
ars used as ingredients would not lead to an increase 
in  the  yield  of  acetaldehyde  in  commercial  cigarettes 
(Seeman et al�, 2002)� This conclusion was questioned in 
a more recent review (Talhout et al�, 2006) on the basis 
of two particular studies, in which sugars were added to 
experimental cigarettes at levels of up to 20%, resulting 
in increases in aldehyde yields per cigarette (Zilkey et al�, 
1982; Shelar et al�, 1992)� However, these cigarettes were 
so heavily loaded with sugars that the burning character-
istics changed leading to an increase in tar yield as well� 
If based on tar yield, the relative yield of acetaldehyde 
did not change in one study (Zilkey et al�, 1982; without 
using those cigarettes containing a tobacco substitute or 
with charcoal filtration) or only changed in one of two 
sets of experimental cigarettes (Shelar et al�, 1992) as a 
function of the sugar application level� Furthermore, it 
remains questionable if results obtained at 16–20% sugar 
application levels can indeed be meaningfully back-ex-
trapolated and would thus be relevant for the maximum 
5% levels used in most commercial cigarettes� The lack of 
a relevant acetaldehyde effect in the above two studies 
with normalization to tar yields is in line with the results 
of benchmark studies evaluating the smoke composition 
of major brands of cigarettes in a given market, showing 
that the acetaldehyde yield was found to be tightly cor-
related with the tar yield (data from Gregg et al�, 2004; 
Counts et al�, 2005; Hyodo et al�, 2007), while no correla-
tion with sugar content was found for the acetaldehyde 
yield, neither absolute per cigarette nor relative to tar 
yield (Phillpotts et al�, 1975; Seeman et al�, 2003)� In a 
study using ingredient combinations including sugars, 
acetaldehyde yields relative to tar slightly decreased in 
the groups using sugars as ingredients, while the same 
data relative to nicotine were found to slightly increase 
(by up to 11%, not dependent on sugar application level) 
(Rustemeier et al�, 2002)� A trend to slightly higher acetal-
dehyde yields (by up to 23%, nicotine-based, not depen-
dent  on  sugar  application  level)  was  also  observed  in 
another ingredient mixture study with sugar application 
levels up to 10�5% (Baker et al�, 2004b)� Thus, although 
few  individual  studies  may  have  found  sugar-related 
increases  in  acetaldehyde  yield,  this  is  not  apparent 
in  most  others,  in  particular  in  those  using  cigarettes 
with designs that are closer to commercial cigarettes� In 
addition, acetaldehyde yields need to be normalized to 
those of tar or nicotine to correct for potential changes 
in burning characteristics in case of high experimental 
sugar applications�
In an experimental study using radiolabeled glucose 
and sucrose added to research cigarettes, up to 0�06% of 
the label was found in acetaldehyde (Gager et al�, 1971b), 
which at a sugar application level of 5% (40 mg per ciga-
rette) would translate to an ingredient-related contribu-
tion to the overall acetaldehyde yield of approximately 
5%, assuming an average overall yield of acetaldehyde of 
approximately 500 µg per cigarette�
Taken together, sugars used as ingredients do not pro-
duce greater yields of acetaldehyde in mainstream smoke 
than are produced from tobacco itself, which they replace 
as an ingredient on a weight-for-weight basis (Seeman 
et al�, 2002)� This conclusion is important considering the 
suggestions that sugars could be added with the intention 
to increase the yield of acetaldehyde so as to increase the 
addictive potency of cigarette smoke by interacting with 
nicotine or by the formation of derivatives with biogenic 
amines (Belluzzi et al�, 2005; Talhout et al�, 2006; Rabinoff 
et al�, 2007; Talhout et al�, 2007; European Commission 
Health  and  Consumer  Protection  Directorate-General 
Scientific Committee on Emerging and Newly Identified 
Health Risks, 2010)�
5.2.3.  Acrolein and 2-Butanone
The nicotine-based yield of acrolein increased slightly 
with increasing sugar application levels, resulting in an 
additional yield of 10% at a 5% sugar application level 
compared to the control with no added sugar (Table 3, 
Figure 3C)� Statistically significant increases were found 
in three of the eight individual studies under ISO condi-
tions and also in one case under HCI conditions� As was 
argued in the report of one of these studies, there is an 
appreciable  long-term  analytical  variability  of  similar 
magnitude  as  the  sugar-related  effect  (Baker,  2006)�  If 
sugars were used in a mixture of ingredients, there was 
a  slight  increase  in  nicotine-based  acrolein  yields  (up 
to 18%, not dependent on sugar application level) but a 
decrease if related to tar yield (Rustemeier et al�, 2002)� 
A trend to increased acrolein yields (up to 24%, nicotine-
based, independent of the sugar application level) was 
also observed in another ingredient mixture study with 
sugar  application  levels  of  up  to  10�5%  (Baker  et  al�, 
2004b)�
The nicotine-based yield of another C4-carbonyl con-
stituent, i�e� 2-butanone or methyl ethyl ketone, increased 
slightly but statistically significantly with increasing sugar 
application levels, resulting in an additional yield of 9% 
at a 5% sugar application level compared to the control 
with no added sugar when smoked under ISO conditions 
(Table 3)� This effect was not seen under HCI conditions� 
A numerical increase in 2-butanone yields of the same 
magnitude  (nicotine-based,  independent  of  the  sugar 
application level) was also seen in the smoke generated 
from research cigarettes with ingredient mixtures con-
taining sugars at application levels of up to 10�5% (Baker 
et al�, 2004b)�Sugars as cigarette ingredients  257
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In  a  study  using  uniformly  14C-labeled  glucose  and 
sucrose as ingredients, less than 0�01% of the label was 
recovered as acrolein, and 0�02–0�03% of the radiolabel 
was found as 2-butanone (Gager et al�, 1971b)� The most 
important parameter for the yield of both constituents is 
the overall smoke yield of a cigarette, as demonstrated by 
the tight correlation of acrolein yields with those of tar or 
carbon monoxide in various series of commercial ciga-
rettes (data from Gregg et al�, 2004; Counts et al�, 2005; 
Hyodo et al�, 2007)�
5.2.4.  Volatile Hydrocarbons
There was a rather consistent increase in the nicotine-
based yields of benzene (Figure 3D) and toluene with 
increasing sugar application levels among the ISO smok-
ing studies entering the pooled analysis, although the 
overall increases in yield at the 5% sugar application lev-
els were relatively low (9%, Table 3)� If tested under HCI 
conditions, there was no sugar-related effect observed for 
either of these two constituents but there was for styrene, 
a constituent with similar chemical structure�
Increases in nicotine-based yields of benzene and tolu-
ene of up to 13 and 25%, respectively, were also observed 
in one study on research cigarettes with added tobacco 
ingredient mixtures containing sugars (Rustemeier et al�, 
2002), but not in another (Baker et al�, 2004b)� The obser-
vations in the first ingredient mixture study may simply 
be due to the replacement of nicotine-containing tobacco 
with the ingredient mixture, thus lowering the normal-
ization basis for the specific constituent yields, because 
these effects were absent if yields were related to tar� Such 
effects may of course also be related to other components 
of the ingredient mixtures than sugars� Again, the yield of 
these two smoke constituents correlated well with tar or 
carbon monoxide yields in the smoke of commercial cig-
arettes (data from Gregg et al�, 2004; Counts et al�, 2005; 
Hyodo et al�, 2007)� Although it may be conceivable that 
benzene could be formed from the C6 structure of mono-
saccharides, less than 0�01% of radiolabeled glucose or 
sucrose  was  found  to  be  converted  to  benzene  when 
added to experimental cigarettes (Gager et al�, 1971b)�
A 12% increase of the nicotine-based yield of isoprene 
was observed in the pooled analysis of the data gener-
ated under ISO conditions� This was not observed under 
HCI conditions�
5.2.5.  N-Nitrosamines
The  increased  yield  seen  for  some  carbonyl  constitu-
ents  may  be  related  to  the  decreased  yields  for  some 
nitrogen-containing  mainstream  smoke  constituents, 
because  some  carbonyl  compounds  may  trap  nitro-
gen-containing  precursors  of  these  constituents�  The 
nicotine-based  yields  of  N-nitrosodimethylamine  and 
N-nitrosonornicotine  were  found  to  decrease  with 
increasing sugar application levels, and approximately 
70% of the variability seen for the two constituents can 
be explained by the sugar application (Table 3)� At the 5% 
application level, this would result in decreased yields 
of 12% compared to a control without added sugars� No 
effect was found for N-nitrosonornicotine, if smoke was 
generated under HCI conditions� Interestingly, there is no 
trend for the NNK yields (nicotine-based), which might 
be  explainable  by  the  higher  proportion  of  NNK  pre-
formed in the tobacco versus its formation during smok-
ing in comparison to N-nitrosonornicotine (Moldoveanu 
and Borger Ding, 2008)� There were clearly two distinct 
classes of yields for the tobacco-specific N-nitrosamines 
(Figure 3E)� This may be related to diverging analytical 
methodologies but may also reflect different generations 
of research cigarettes with lowered preformed contents 
of  tobacco-specific  N-nitrosamines  in  the  tobacco  of 
more recent productions (Boyette and Hamm, 2001)�
Decreases  for  the  nicotine-based  yields  of  both 
N-nitrosonornicotine and NNK were found in the smoke 
of the research cigarettes with sugar-containing mixtures 
(Rustemeier et al�, 2002)� In another ingredient mixture 
study, N-nitrosonornicotine yields were more decreased 
than NNK yields (Baker et al�, 2004b)� For commercial 
cigarettes,  there  is  a  categorical  difference  between 
American-blend and Virginia-type cigarettes due to the 
higher nicotine content in Burley tobacco, and the yields 
of the tobacco-specific N-nitrosamines in general corre-
late less with those of other constituents (data from Gregg 
et al�, 2004; Counts et al�, 2005; Hyodo et al�, 2007)�
5.2.6.  4-Aminobiphenyl
The  nicotine-based  yields  of  several  aromatic  amines 
decreased  with  increasing  sugar  application  levels,  an 
effect which was statistically significant for 4-aminobi-
phenyl (Table 3, Figure 3F)� At a 5% sugar application 
level, this would result in a 21% decrease of the 4-amino-
biphenyl yield� This is in line with the above-mentioned 
scavenging of nitrogen-containing intermediates by car-
bonyls, which are formed in slightly increased amounts 
during  the  pyrolysis  of  the  sugars�  The  effect  was  not 
seen if tested under HCI smoking conditions� A trend 
to  decreased  yields  of  4-aminobiphenyl  (up  to  19%, 
nicotine-based) was also observed for the smoke from 
research  cigarettes  with  ingredient  mixtures  contain-
ing sugars (Baker et al�, 2004b)� The absolute yields of 
4-aminobiphenyl  and  the  other  aromatic  amines  are 
relatively low (low ng range per mg nicotine) compared 
to those of the above-mentioned constituents, such as 
the aldehydes (high µg range per mg nicotine)� As for 
other  nitrogen-containing  smoke  constituents,  there 
are  categorical  differences  between  American-blend 
and Virginia-type cigarettes due to the higher nicotine 
content in Burley tobacco (data from Gregg et al�, 2004; 
Counts et al�, 2005; Hyodo et al�, 2007)�
5.3.  Additional constituents of mainstream smoke
Additional studies were performed to characterize the 
effect  of  using  sugars  as  tobacco  ingredients,  which 
analyzed  less  comprehensive  lists  of  smoke  constitu-
ents  compared  to  the  above  experiments�  Pyrolysis 
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from  sugars�  An  almost  threefold  increase  in  furfural 
yield  (nicotine-based)  was  indeed  found  in  chemical-
analytical studies on the smoke from Burley cigarettes 
with fructose and/or glucose at application levels up to 
18% (Thornton and Massey, 1975)� Since Burley is practi-
cally devoid of sugars, this study also showed that other 
tobacco components also give rise to the formation of 
furfural� Cigarettes made of Virginia tobacco with high 
natural  sugar  content  (17%)  also  had  about  threefold 
higher furfural yields than the Burley cigarettes, which 
further increased by glucose application� This study also 
confirmed the general increase in carbonyl constituents 
by the presence of sugars in the tobacco blend�
With  radioactive  labeling,  further  products  of  glu-
cose  and  sucrose  used  as  cigarette  ingredients  were 
identified in mainstream smoke (Gager et al�, 1971a,b)� 
These include furan, alkylated derivatives of furan, and 
acetonitrile�  None  of  these  constituents  was  found  at 
recoveries of more than 0�07% of the added tracer� Some 
constituents found in this tracer study were also included 
in  the  above  pooled  analysis  of  mainstream  smoke 
constituents, but did not show a statistically significant 
increase with increasing sugar application levels in the 
pooled analysis� These constituents include acetone and 
crotonaldehyde� Acetone had the highest radiochemical 
yield of 0�1% of the added tracer identified, which at a 
sugar application level of 5% (40 mg per cigarette) would 
translate to a sugar-related contribution to the overall 
acetone  yield  of  approximately  10–15%,  assuming  an 
average overall yield of acetone of approximately 300 µg 
per cigarette� Two of four individual studies of the pooled 
analysis indeed showed a statistically significant increase 
in nicotine-based acetone yields� No effect was seen in 
the pooled analysis for crotonaldehyde�
5.4.  Summary, mainstream smoke chemistry
The  mainstream  smoke  of  research  cigarettes  manu-
factured without added sugar or with several levels of 
sugars applied as tobacco ingredients was quantitatively 
analyzed for constituents that have been considered to 
be of major toxicological relevance� The results of sev-
eral studies of similar designs were pooled to increase 
the  power  of  the  statistical  analyses  in  this  review�  In 
general, under ISO smoking conditions, a trend towards 
increasing  nicotine-based  yields  of  carbonyl  constitu-
ents  was  observed,  although  with  distinct  differences 
among  the  particular  carbonyl  constituents�  The  most 
important  increases  were  observed  for  formaldehyde 
and  acrolein�  A  notable  exception  was  acetaldehyde, 
which did not change with increasing sugar application 
levels�  Furthermore,  a  decrease  in  the  nicotine-based 
yields  of  several  nitrogen-containing  constituents  was 
observed� The trends observed in this pooled analysis are 
in line with the findings of pyrolysis experiments� Similar 
trends  were  also  observed  if  sugars  were  major  parts 
of  ingredient  mixtures  applied  to  research  cigarettes� 
Sugar  application-dependent  effects  were  found  to  be 
less  pronounced  if  smoke  was  generated  under  more 
intense smoking conditions� It should be considered that 
although the pooled analysis covers a list of 36 smoke 
constituents, which are considered representative of the 
major chemical classes of smoke constituents, it is only 
a small percentage of the number of approximately 5000 
constituents  currently  known  (Rodgman  and  Perfetti, 
2009)�
It is of note that all results in this section were based 
on the respective nicotine yield of the research cigarettes, 
which had to decrease with increasing sugar application 
levels� Thus, the nicotine-based yield data obtained in 
the individual or pooled analyses need to be interpreted 
in view of a trend to decreasing nicotine yields, which 
automatically  could  be  considered  an  exaggeration  of 
positive trends or an attenuation of negative trends with 
increasing sugar application levels compared to a more 
conventional way of reporting smoke constituent data on 
the basis of the number of cigarettes smoked or TPM or 
tar levels�
5.5.  Toxicological interpretation of changes in 
mainstream composition
The pooled analysis revealed complex changes in smoke 
composition  with,  e�g�  known  human  carcinogens 
increasing and decreasing in yield, which is difficult to 
interpret, in particular in view of the unclear etiology of 
smoking-related chronic diseases� Moreover, known haz-
ards and risks of these compounds do in general not refer 
to them as constituents of a complex mixture but rather 
as  neat  compounds�  Of  the  constituents  identified  as 
increasing with increasing sugar application levels, form-
aldehyde and benzene are classified as known human 
carcinogens, with predominant risks for nasopharyngeal 
cancer  and  hematopoietic  malignancies,  respectively 
(International  Agency  for  Research  on  Cancer,  1982; 
International  Agency  for  Research  on  Cancer,  2006)� 
N-nitrosonornicotine  and  4-aminobiphenyl,  the  yields 
of which were found to decrease with increasing sugar 
application levels, are also classified as human carcino-
gens (International Agency for Research on Cancer, 2007; 
Baan  et  al�,  2008)�  N-Nitrosonornicotine  can  produce 
respiratory tract tumors in laboratory animals and has 
been classified as human carcinogen based on mechanis-
tic considerations, whereas 4-aminobiphenyl increases 
the risk for bladder cancer�
A  role  of  these  smoke  constituents  in  develop-
ing  smoking-related  cancer  has  been  suggested  but 
is  unclear  in  terms  of  quantitative  contributions  and 
modes of action� For example, apart from the causal role 
for nasopharyngeal cancer, the International Agency for 
Research on Cancer argued that the overall balance of 
epidemiological  evidence  would  not  support  a  causal 
role of exposure to formaldehyde vapor for developing 
cancer of the oral cavity, oro-and hypopharynx, larynx, 
and lung (International Agency for Research on Cancer, 
2006)� Smoking has been associated with pharynx cancer 
(US Department of Health and Human Services, 2004), 
and  thus,  formaldehyde  exposure  from  smoking  may Sugars as cigarette ingredients  259
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well contribute to this disease� Moreover, smokers are 
not exposed to just formaldehyde vapor but the whole 
complex  matrix  of  smoke  constituents,  with  a  part  of 
the smoke-borne formaldehyde residing in the particu-
late matter of smoke (Baker and Chang, 1999)� This may 
change its potency and target organ specificity relative to 
pure formaldehyde inhalation� Using cancer extrapola-
tion models from rats to humans (Conolly et al�, 2004), 
it can be calculated that the daily average formaldehyde 
concentration a smoker would be exposed to would be 
around a “de minimis risk” of 10−6 for lifetime exposure 
depending on the model used, and this would also hold 
true  for  any  additional  formaldehyde  exposure  from 
using sugars as ingredients (Roemer et al�, 2010)� This 
estimate is much below the epidemiologically observed 
risk  for  respiratory  tract  cancer  by  smoking�  However, 
this estimate is based on a model with large uncertain-
ties (Crump et al�, 2008), using one of several ways of 
assessing the exposure from smoking, and it may or may 
not mirror the actual role of formaldehyde in smoking-
related carcinogenesis�
The  proportion  of  smoking-induced  total  leukemia 
and acute myeloid leukemia attributable to the benzene 
taken up from cigarette smoke was assessed by combin-
ing epidemiologic data on the health effects of smoking 
with risk assessment techniques for low-dose extrapo-
lation (Korte et al�, 2000)� The authors concluded that 
based on their modeling assumptions benzene would be 
estimated to be responsible for approximately 10–50% of 
smoking-induced total leukemia mortality� If this would 
indeed be the case, a further 9% increase at the maximum 
use level of sugars as ingredients could be meaningful�
Acrolein is the strongest irritant (Dorman et al�, 2008) 
in the group of constituents with increased yields with 
increasing sugar application level� It has been suggested 
to play a role in smoking-related pathogeneses (Hecht, 
2006; Rahman and Adcock, 2006) but, as for all other 
constituents, no quantitative attribution to the etiology 
of smoking-related diseases has been established� Thus, 
it is not obvious how to interpret these relative changes 
with increasing sugar application level in terms of the 
overall risks for cancer and non-malignant diseases for 
smokers�
Acrolein,  benzene,  formaldehyde,  and 
N-nitrosonornicotine are also in the list of nine that was 
recommended for regulatory control of cigarette emis-
sions  (Burns  et  al�,  2008;  World  Health  Organization 
Study  Group  on  Tobacco  Product  Regulation,  2008)� 
4-Aminobiphenyl is in the secondary list considered high 
priority for disclosure and monitoring�
The  other  smoke  constituents  found  to  increase 
with  increasing  sugar  application  level  in  the  pooled 
analysis  were  2-butanone,  isoprene,  toluene,  and 
benzo[k]fluoranthene,  while  N-nitrosodimethylamine 
decreased�  The  latter  is  currently  classified  as  prob-
ably carcinogenic to humans (International Agency for 
Research  on  Cancer,  1987),  while  isoprene,  benzo[k]
fluoranthene (and styrene, which was increased in the 
combined  analysis  of  the  HCI  data)  are  classified  as 
possibly carcinogenic to humans (International Agency 
for Research on Cancer, 1999; International Agency for 
Research  on  Cancer,  2002;  International  Agency  for 
Research on Cancer, 2010)� Toluene is not classifiable 
as to its carcinogenicity to humans, and 2-butanone is 
not listed at all� For non-cancer effects, toluene has been 
regulated based on neurological effects seen in humans 
(US  Environmental  Protection  Agency,  2005),  while 
2-butanone has been regulated based on developmental 
toxicity (US Environmental Protection Agency, 2003)� It 
is unclear whether any of the above toxicological proper-
ties of these constituents are indeed relevant for human 
smoking-related diseases�
Within the scope of the current assessment, the find-
ings obtained in the chemical-analytical investigations 
of mainstream smoke were in the following section put 
into the broader perspective of biological toxicological 
tests utilizing the whole smoke or major fractions thereof, 
instead of concentrating on individual smoke constitu-
ents� In further sections, information was considered on 
smoke composition, exposures, and disease risks in major 
markets with predominant use of either American-blend 
or Virginia-type commercial cigarettes, which differ in 
their use of sugars as tobacco ingredients�
6.  Effects of using sugars as ingredients in 
toxicological assays
The  mainstream  smoke  of  research  cigarettes  with-
out or with various levels of sugars was investigated in   
in vitro cytotoxicity and genotoxicity assays, in vivo inha-
lation toxicity studies with primary emphasis on irritative 
changes in the respiratory tract, and in dermal tumorige-
nicity studies� The results of studies with similar design 
were pooled in analogy to the evaluation of the chemical 
composition�
6.1.  In vitro cytotoxicity
Cytotoxicity has been identified as a major toxicologi-
cal activity of mainstream smoke and has been used for 
benchmarking comparisons (Roemer et al�, 2004; Counts 
et al�, 2006), the assessment of filter variations (Gaworski 
et al�, 2009), and cigarette design changes (Tewes et al�, 
2003)�  In  recent  years,  the  Neutral  Red  Uptake  assay 
(adapted from INVITTOX, 1990) has mostly been used 
to assess cytotoxic potential, and it is required for regu-
latory  reporting  purposes  in  Canada  (Health  Canada, 
2000)� Quite often, both the particulate and the gas/vapor 
phases have been tested separately� In order to improve 
the power of the current analysis, studies with applica-
tions of sugars as the sole ingredients (Roemer et al�, 2010; 
Coggins et al�, 2011) were evaluated by linear regression 
analysis� There was a statistically significant decrease in 
cytotoxicity activity for the particulate phase with increas-
ing sugar application levels (Figure 4A, TPM-based com-
parison)� This effect would not have been detected by 
evaluating these studies individually, except for study 3 260  E. Roemer et al.
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using honey as an ingredient (Coggins et al�, 2011)� There 
was  no  change  in  cytotoxic  activity  for  the  gas/vapor 
phase (Figure 4B)� The results of the current analysis are 
consistent with those studies, in which sugars were used 
as a major part of ingredient combinations at individual 
application levels up to 10�5% (Roemer et al�, 2002; Baker 
et al�, 2004a)� In an additional study on the particulate 
fraction and the whole smoke of research cigarettes with 
HFCS at application levels of 3–5% (no control without 
sugar  application),  no  difference  in  cytotoxicity  was 
observed (Stavanja et al�, 2006)� No increase in in vitro 
cytotoxicity (ED50 per puff) or ciliatoxicity (effect after 4th 
puff) was seen in an early study on non-filter American-
blend  or  single-blend  Burley  research  cigarettes  with 
and without 5�3% invert sugar (US Department of Health 
Education and Welfare, 1977)�
6.2.  In vitro genotoxicity
The  mutagenicity  of  the  particulate  fraction  of  main-
stream smoke has mostly been tested in the plate incor-
poration version of the Salmonella typhimurium reverse 
mutation assay, e�g� for the benchmarking comparison of 
commercial cigarettes (Roemer et al�, 2004; Rickert et al�, 
2007b) or for the assessment of changes in cigarette filter 
design (Gaworski et al�, 2009)� This assay is required for 
regulatory reporting in Canada (Health Canada, 2000)� 
For  this  type  of  investigations,  the  respective  OECD 
guideline (Organization for Economic Co-operation and 
Development, 1997a) was adapted to the comparative 
testing of various types of smoke-derived test materials� 
The most sensitive tester strains are TA98 and TA100 in the 
presence of a metabolic activation system (S9)� In pooling 
data sets on sucrose, invert sugar, honey, and HFCS from 
various  studies  and  laboratories  (Roemer  et  al�,  2010; 
Coggins et al�, 2011), mutagenicity data for these two test-
ing conditions did not show any increase in activity with 
increasing  single  sugar  application  levels  (TPM-based 
comparison,  Figure  5A  and  B)�  No  sugar  application-
dependent effect on mutagenicity was reported in any 
of the individual studies, including the results obtained 
with other tester strains and in the absence of metabolic 
activation (e�g� TA1537 with and TA100 without meta-
bolic activation: Figure 5C and D)� Various other studies 
used  sugars  in  ingredient  combinations  at  individual 
sugar levels up to 10�5%; no sugar-related effect on smoke 
mutagenicity was reported for any of these test cigarettes 
(Rodgman, 2002; Roemer et al�, 2002; Baker et al�, 2004a; 
Renne et al�, 2006)� In an additional study using conden-
sate and whole smoke of research cigarettes with HFCS at 
application levels of 3–5% or with 3% HFCS replacing 3% 
corn syrup/invert sugar casings (no control without sugar 
application), no difference in bacterial mutagenicity was 
observed (Stavanja et al�, 2006)� Also, no difference was 
detected for these variations in sugar application in a sis-
ter chromatid exchange assay in Chinese hamster ovary 
cells�  Similarly,  comparing  the  use  of  5%  invert  sugar 
versus that of 5% honey did not reveal any differences in 
response in genotoxicity assays (Stavanja et al�, 2003)� In 
an earlier study, in which cigarettes were soaked in solu-
tions containing various types of sugars, also no increase 
in bacterial mutagenicity was observed for TA100 and 
rather a decrease for TA98 (Sato et al�, 1979)�
6.3.  Subchronic inhalation toxicity
Subchronic  inhalation  toxicity  studies  in  rats  have 
become  the  most  commonly  used  in  vivo  study  type 
for  the  investigation  of  potential  effects  of  changes  in 
cigarette design on mainstream smoke toxicity (Terpstra 
et al�, 2003), tobacco processing (Theophilus et al�, 2003), 
or cigarette benchmarking comparisons (Patskan et al�, 
2008)� Several studies were reported in which the effects 
of using sugars as tobacco ingredients on the toxicity of 
mainstream smoke were investigated� These studies were 
in  general  conducted  in  accordance  with  the  respec-
tive guidance from OECD (Organization for Economic 
Figure 4.  Cytotoxicity (EC50, TPM-based) of the mainstream smoke 
particulate  and  gas/vapor  phases  of  research  cigarettes  with 
varying sugar application levels relative to the respective control. 
Linear regression with 95% confidence limits was performed. The 
legend in graph A also applies to graph B; for study references, 
see Table 3.Sugars as cigarette ingredients  261
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Co-operation and Development, 2009) with adaptation 
to  the  comparative  investigation  of  smoke  generated 
from  different  research  cigarettes�  During  the  90-day 
inhalation period, clinical observations were conducted, 
body weight and food consumption were measured, and 
pulmonary function tests were performed� At scheduled 
necropsies,  blood  was  collected  for  clinical  pathology 
measurements,  major  organs  were  weighed,  and  tis-
sues were collected for histopathological evaluation� The 
major emphasis in these studies was on potential effects 
in the respiratory tract� Some studies included a 42-day 
post-inhalation period to investigate the sustained devel-
opment or recovery of effects�
The effects of sucrose and invert sugar, each at vari-
ous application levels, were investigated in a large study, 
which shared the same control without sugar application 
(Table 4) (Coggins et al�, 2011)� At nominal TPM concen-
trations of 150 mg/m3, an increase in the formaldehyde 
concentration  in  the  test  atmospheres  was  observed 
that was dependent on the sugar application level� No 
such increase was found for acetaldehyde and acrolein� 
Analysis of exposure markers, such as blood cotinine or 
carboxyhemoglobin levels, as well as respiratory param-
eters,  documented  similar  inhalation  for  the  groups 
exposed to the smoke generated from the research ciga-
rettes with the various levels of sugar applications� The 
usual smoke inhalation-related biological effects, such 
as a decreased gain in body weight and irritative changes 
in the respiratory tract epithelia, were observed� There 
was only one significant difference in histopathological 
findings between the groups exposed to the smoke gen-
erated from the research cigarettes with the highest sugar 
application level (10%) and that of the control without 
added sugars (Table 4): Increased incidence and severity 
score for respiratory epithelial hyperplasia at nasal level 
2 was observed in male but not in female rats at the high 
Figure 5.  Bacterial mutagenicity (TPM-based) of the mainstream smoke particulate phase of research cigarettes with varying sugar 
application levels relative to the respective control. Selected conditions are tester strains TA98 and TA100 with metabolic activation (+S9) 
(A, B) and TA1537 and TA100 without metabolic activation (–S9) (C, D). Linear regression with 95% confidence limits was performed. The 
legend in graph A also applies to graphs B to D; for study references, see Table 3.
Table 4.  Histopathological findings (mean severity scores) with significant differences between rats exposed to the smoke of research 
cigarettes with and without sugars applied as tobacco ingredients at the end of at least one subchronic rat inhalation study on 
mainstream smoke from research cigarettes with various application levels of sugars: sucrose and invert sugar (Coggins et al., 2011).
Finding Gender
Control Sucrose Invert sugar
0% 3.6% 7.2% 10% 2.5% 5% 10%
Nose level 1, M 2.3 2.0 1.9 2.6 2.3 2.8 2.8
goblet cell hyperplasia F 1.0 0.8 0.5 1.3 1.1 1.6 0.7
Nose level 2, M 0.7 0.8 1.0 1.7 1.3 1.1 1.6
respiratory epithelium hyperplasia F 1.2 0.8 0.7 1.2 0.9 0.9 0.9
Nose level 2, M 0.0 0.1 0.0 0.5 0.0 0.0 0.0
olfactory epithelium atrophy F 0.7 0.8 0.4 1.6 0.3 0.6 1.0
Nose level 3, M 0.0 0.0 0.0 0.0 0.0 0.0 0.0
olfactory epithelium atrophy F 0.2 0.6 0.3 0.9 0.0 0.3 0.7
Larynx, arytenoid projections M 2.3 1.8 1.9 2.2 2.1 2.1 2.2
squamous metaplasia F 3.0 2.1 1.4 2.2 1.8 2.5 2.6
Severity scores on a scale of 0 to 4.
Additional groups not shown here: Air-exposed sham group as negative control, groups exposed to mainstream smoke of 1R4F standard 
reference cigarettes as quality control.
Bold print: significant effect compared to control (ANOVA followed by Dunnett’s test, or if there was an increase of >1.0 in the severity 
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sucrose  application  level�  Significant  differences  were 
not observed for the low and medium sugar application 
levels (up to 7�2%)� After a 42-day post-inhalation period, 
this effect had recovered� A few other findings were higher 
in rats previously exposed to smoke from cigarettes con-
taining the highest sugar level than in those rats exposed 
to smoke from control cigarettes in one but not the other 
gender�
The  same  laboratory  conducted  another  large  sub-
chronic inhalation study with the same study design, in 
which research cigarettes with various application levels 
of HFCS alone (Coggins et al�, 2011) or in combination 
with invert sugar and sucrose were investigated (Table 5)� 
The concentrations of formaldehyde but not those of acet-
aldehyde or acrolein in the test atmospheres increased 
with increasing sugar application levels� The only signifi-
cant effects in this study were significantly higher goblet 
cell hyperplasia scores in the tracheas of female rats in 
groups exposed to the smoke of the test cigarettes with 
dual combinations of sugars at a total 6�6% application 
level� This effect was not seen with 6�6 or even 10% of 
HFCS alone or with the triple sugar combination at 9�9%, 
nor was it seen in the male rats� Few incidental effects 
were seen after the end of the post-inhalation period�
A third subchronic inhalation study was conducted 
by the same laboratory and with the same study design 
using  honey  as  the  ingredient  to  be  tested  (Coggins 
et al�, 2011)� Again, formaldehyde concentrations in the 
test atmospheres were found to increase with increas-
ing honey application levels in the test cigarettes, while 
there was no effect on the other aldehydes determined� 
The histopathological endpoints that showed significant 
sugar  application-dependent  differences  in  the  above 
studies that tested sucrose, invert sugar, and HFCS were 
not different in this study (Table 6)� However, a significant 
increase was seen for bronchial goblet cell hyperplasia 
in both males and females at the highest honey appli-
cation level compared to control� No other significant 
differences were observed in the groups exposed to the 
smoke of the research cigarettes with honey, except of 
an increase in severity of olfactory epithelium atrophy at 
nose levels 2 and 3 of the male rats in the group exposed 
to the smoke of the research cigarettes with 6�6% honey� 
Such significant difference was not seen in female rats� 
There were no differences apparent after a 6-week post-
inhalation period� No effect was seen at the 4�8% honey 
level, which is close to the maximum use level of sugar 
applications in most commercial cigarettes� Thus, in the 
current inhalation study, significant changes in groups 
exposed to smoke from research cigarettes with applied 
sugars vs� control groups were seen in endpoints again 
differing in comparison to the other two subchronic inha-
lation studies, and these changes had not been detected 
in the previous studies (Tables 4 and 5)�
Although there were some significant differences in 
the  groups  exposed  to  the  smoke  generated  from  the 
research cigarettes with the highest sugar application lev-
els, these were not consistently found when comparing 
between genders or between studies, suggesting that the 
few findings recorded were possibly due to chance rather 
than causally linked to the use of sugars as tobacco ingre-
dients in these research cigarettes� If these differences 
would be triggered by the high sugar application level, 
one would expect to see very similar differences across 
Table 5.  Histopathological findings (mean severity scores) with significant differences between rats exposed to the smoke of research 
cigarettes with and without sugars applied as tobacco ingredients at the end of at least one subchronic rat inhalation study on 
mainstream smoke from research cigarettes with various application levels of sugars: high fructose corn syrup (HFCS), single (Coggins 
et al., 2011) and in combinations with sucrose and invert sugar.
Finding Gender
Control
0%
HFCS
HFCS + 
Sucrose
3.3 +
3.3%
 
HFCS +  
Invert Sugar
3.3 +
3.3%
 
Sucrose + 
Invert Sugar
3.3 +
3.3%
 
HFCS +Sucro +   
Invert Sugar
3.3+
3.3+
3.3% 3.3% 6.6% 10%
Nose level 1, M 2.2 1.2 1.9 2.2 1.6 1.4 1.8 1.6
goblet cell hyperplasia F 1.4 0.9 0.8 1.5 0.7 0.8 1.0 0.2
Nose level 2, M 2.1 1.7 2.4 2.2 1.6 1.8 2.0 1.8
respiratory epithelium hyperplasia F 1.8 1.2 1.2 2.0 1.6 1.0 1.4 1.0
Nose level 2, M 0.4 0.2 0.6 0.1 0.8 0.2 0.4 0.5
olfactory epithelium atrophy F 1.0 0.3 1.6 1.2 1.7 0.4 0.9 1.1
Nose level 3, M 0.0 0.0 0.0 0.0 0.5 0.2 0.5 0.0
olfactory epithelium atrophy F 0.5 0.0 1.0 0.4 0.9 0.0 0.9 0.4
Larynx, arytenoid projections M 3.8 3.5 3.8 3.7 3.7 3.9 3.7 3.7
squamous hyperplasia − metaplasia F 3.7 3.9 3.6 3.6 3.7 3.7 3.8 3.9
Trachea, M 2.6 2.1 2.8 1.9 3.2 2.7 3.3 3.3
goblet cell number/hyperplasia F 2.3 2.6 3.1 2.6 3.7 3.7 3.4 1.7
Left lung, M 3.2 2.5 3.3 2.6 3.4 3.2 3.3 3.5
goblet cell number/hyperplasia F 3.5 3.0 3.2 3.6 3.9 3.6 4.0 2.4
Right lung, M 2.2 2.0 1.8 1.6 2.7 2.0 2.3 2.3
goblet cell number/hyperplasia F 2.7 3.0 2.3 3.1 3.4 2.6 3.3 1.9
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those studies and across the sugars tested, based on the 
similarity  of  the  changes  determined  in  the  compre-
hensive chemical-analytical studies on the mainstream 
smoke of these research cigarettes (see above)� In any 
case, these differences were only observed at application 
levels higher than those usually applied to commercial 
cigarettes, although findings at exaggerated application 
levels may be indicative of effects at commercial applica-
tion levels�
More light may be shed on this question by examin-
ing additional subchronic inhalation studies, in which 
research cigarettes with combinations of tobacco ingredi-
ents, including a major contribution of sugars, were eval-
uated� A study with similar design to the ones discussed 
above had sucrose and invert sugar incorporated into a 
an ingredient mixture with total sugar application levels 
of 3�3 and 5�1% (Vanscheeuwijck et al�, 2002)� Very simi-
lar smoke inhalation-dependent effects were seen, e.g. 
reduced body weight gain and histopathological findings 
in the respiratory tract� None of the differences discussed 
above for the sugar application studies was seen as a func-
tion of the ingredient mixture application� Among the 
multitude of endpoints investigated, there was only one 
significant increase observed for respiratory epithelium 
hyperplasia at nose level 1 in female but not male rats in 
the high sugar combination group� In another large study, 
brown and white sugar as well as invert sugar were used 
on research cigarettes as major part of different tobacco 
ingredient  combinations  at  levels  of  6�2,  10�5  and  7%, 
respectively (Baker et al�, 2004a)� The authors concluded 
that there were no discernible differences in the type or 
severity of treatment-related changes in the presence or 
absence  of  the  ingredient  combinations  that  included 
sucrose (as brown or white sugar) or invert sugar, since 
there were no statistically significant differences between 
rats exposed to the smoke from the control and test ciga-
rettes in any of the 32 histopathological endpoints� There 
was also no difference in the histopathological findings 
in another subchronic rat inhalation study comparing 
research  cigarettes  with  and  without  ingredient  com-
binations, of which one included invert sugar at a final 
application level of 2% (Renne et al�, 2006)� These authors 
concluded  that  the  presence  of  flavoring  and  casing 
ingredients did not significantly change the type or extent 
of toxicological effects observed in rat inhalation studies� 
As for some in vitro endpoints, no differences in response 
in subchronic inhalation studies in rats were observed if 
one type of sugar was replaced by another at the same 
application level (no controls without sugar application; 
Stavanja et al�, 2003; Stavanja et al�, 2006)�
6.4.  In vivo genotoxicity
As part of the above subchronic inhalation studies with 
single sugar ingredients (studies 1, 2, and 4 using sucrose, 
invert sugar, or high fructose corn syrup), the formation 
of micronuclei in rat bone marrow polychromatic eryth-
rocytes and peripheral reticulocytes was investigated as 
an endpoint for in vivo clastogenicity (in basic accor-
dance  with  Organization  for  Economic  Co-operation 
and Development, 1997b)� Peripheral reticulocytes were 
analyzed  using  a  flow  cytometric  method  capable  of 
differentiating very young cells to overcome the splenic 
trapping of micronucleated cells which could have con-
founded  this  rat  model  (van  Miert  et  al�,  2008;  Lynch 
et al�, 2011)� Inhalation exposure to mainstream smoke 
for up to 13 weeks did not increase the incidence rates 
of micronucleated reticulocytes in circulating blood, nor 
micronucleated erythrocytes in bone marrow compared 
with sham-exposed controls (data not shown)� Although 
there  were  occasional  significant  differences  between 
Table 6.  Histopathological findings (mean severity scores) with significant differences between rats exposed to the smoke of research 
cigarettes with and without honey applied as tobacco ingredient at the end of at least one subchronic rat inhalation study on mainstream 
smoke from research cigarettes with various application levels of sugars (Coggins et al., 2011).
Finding Gender
Control Honey
0% 3.3% 4.8% 6.6%
Nose level 1, M 2.1 1.8 2.6 1.8
goblet cell hyperplasia F 1.5 1.3 1.7 1.5
Nose level 2, M 2.3 1.8 2.4 2.2
respiratory epithelium hyperplasia F 2.3 2.3 2.2 2.4
Nose level 2, M 0.2 1.0 0.5 1.9
olfactory epithelium atrophy F 1.0 1.3 1.0 1.7
Nose level 3, M 0.0 0.5 0.2 1.1
olfactory epithelium atrophy F 0.5 0.6 0.1 1.0
Larynx, arytenoid projections M 3.6 3.7 3.6 3.3
squamous hyperplasia − metaplasia F 3.5 3.1 3.1 3.6
Trachea, M 2.0 1.3 2.9 2.4
goblet cell number/hyperplasia F 1.3 1.6 1.1 1.2
Left lung, M 2.2 1.9 3.0 2.8
goblet cell number/hyperplasia F 2.6 2.3 2.6 2.8
Right lung, M 1.5 1.6 2.0 2.5
goblet cell number/hyperplasia F 1.4 1.7 1.7 2.4
Conditions as in Table 4, but with 1R4F and 2R4F as quality controls.264  E. Roemer et al.
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the groups exposed to smoke from cigarettes containing 
sucrose and invert sugar and those exposed to smoke 
from control cigarettes without added sugars, the over-
all conclusion was that the sugars had no impact on the 
formation  of  micronucleated  red  blood  cells�  Positive 
control samples responded in accordance to historical 
data from the same laboratory at all time points, indicat-
ing sensitivity of the rats to materials producing micro-
nucleated cells�
6.5.  Carcinogenicity studies
For a long time, mouse dermal carcinogenicity studies 
have been the only cancer bioassay available for cigarette 
smoke (reviewed by Coggins, 2007; Walaszek et al�, 2007)� 
In this assay, mainstream smoke condensate is chroni-
cally painted on the dorsal skin of mice, and skin tumors 
are the major biological response, which can be non-inva-
sively examined on a daily basis� There are two principle 
experimental variants for this assay: Condensate is either 
applied to the skin during the whole experimental period 
as a test for complete carcinogenesis, or condensate is 
applied during the major experimental period of the study 
as a test for its promoting activity after initial treatment 
with a low dose of a known mouse dermal carcinogen, 
low enough not to lead to tumors on its own� There is one 
set of experiments, in which cigarettes with and without 
invert sugar were compared in a complete carcinogenesis 
model (US Department of Health Education and Welfare, 
1977)� The standard experimental blend in this study was 
made according to then non-filter American-blend ciga-
rettes and included 5�3% invert sugar� It was compared to 
the same blend but without sugars� Groups of mice were 
treated with two doses of each condensate for 18 months� 
The major outcome of the study was the estimated prob-
ability of tumor avoidance and the estimated time until 
which 75% of the mice were without skin tumors based 
on  life-table  calculations�  Statistical  analysis  revealed 
that the research cigarettes with and without invert sugar 
ranked very similarly for both dose groups, i�e� could not 
be differentiated (Table 7)� If the tobacco humectant was 
omitted in one test cigarette, no difference in tumori-
genic potential was seen in comparison to the reference 
cigarette  containing  the  humectant�  However,  if  both 
humectant and invert sugar were omitted, the condensate 
generated from the test cigarette had lower tumorigenic 
activity than that of the control (no explanation offered 
by the authors)� In a parallel experiment, single-blend 
Burley cigarettes without and with sugar addition were 
compared (twice at the same dose) and no difference in 
tumorigenic response of the condensates was observed 
(Table 5)� Notably, in the same study the condensates of 
Burley and American-blend cigarettes could well be dif-
ferentiated�  Taken  together,  these  experiments  suggest 
that sugar by itself had no impact on the tumorigenicity 
of smoke condensate in the mouse dermal carcinogenic-
ity assay�
No other carcinogenicity study is available comparing 
cigarettes with appreciably different levels of sugars� In 
a study to evaluate the tumorigenic activity of research 
cigarettes without and with a combination of flavors, the 
test cigarettes had additional glucose and honey at 0�03% 
each on a background of 2% brown invert sugar syrup 
in both the test and control cigarettes; no difference in 
tumor promoting activity was found between test and 
control cigarette condensates (Gaworski et al�, 1999)� In 
two other dermal tumor promotion studies, one type of 
sugar was replaced by another at the same application 
level,  and  no  differences  in  tumor  promoting  activity 
could be observed in terms of tumor incidences or mul-
tiplicities (5% invert sugar by 5% honey: Stavanja et al�, 
2003; 3% corn syrup/invert sugar by 3% HFCS: Stavanja 
et al�, 2006)�
6.6.  Summary, toxicological assays
Complimentary to the chemical-analytical investigations, 
in vitro cytotoxicity, genotoxicity, subchronic inhalation, 
and carcinogenicity studies have been available for the 
non-clinical  assessment  of  the  toxicological  effects  of 
using sugars as ingredients� At sugar application levels 
up to 10%, which is twice the usual maximum applica-
tion level, no consistent toxicologically relevant changes 
in the activity in these assays were observed; statistically 
significant changes seen in one inhalation study could 
not be confirmed in others using similar types of sugars 
and study designs� This is particularly important in view 
of the statistically significant increases in nicotine-based 
yields of acrolein and formaldehyde observed in smoke 
from cigarettes with increasing sugar application level� 
Table 7.  Dermal tumorigenicity of mainstream smoke condensate generated from research cigarettes with and without invert sugar as 
tobacco ingredient.
Research cigarette type Condensate dose group
Estimated probability of tumor  
avoidance (M ± SE)
Estimated number of days until 75%  
of mice remained free of tumors
No invert sugar With invert sugar No invert sugar With invert sugar
Standard experimental 
blend III
12.5 mg 0.715 ± 0.053 0.711 ± 0.026 529 515
  25 mg 0.432 ± 0.060 0.449 ± 0.028 376 414
Burley blend* 12.5 mg 0.508 ± 0.059 0.586 ± 0.056 420 452
  12.5 mg 0.532 0.509 417 372
Life-table-corrected data (US Department of Health Education and Welfare, 1977) (no sugar-dependent differences for formaldehyde, 
acetaldehyde, acrolein, and tar yields).
*Two times low dose; Burley blend and standard experimental blend III tumor probability data (low dose) were statistically significantly 
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Formaldehyde and in particular acrolein play relatively 
prominent roles in the in vitro cytotoxicity assay (Tewes 
et al�, 2003) and can elicit irritative effects in the upper 
respiratory  tract  in  rat  subchronic  inhalation  studies 
(Feron et al�, 1978; Woutersen et al�, 1987)� The acrolein 
concentrations in the above described smoke inhalation 
studies (<1�1 mg/m3) (Coggins et al�, 2011) were similar to 
the lowest observed effect levels in this subchronic model 
for  histopathological  changes  in  the  nose,  the  lateral 
wall respiratory epithelium being the most sensitive site 
(Dorman et al�, 2008)� At higher acrolein concentrations, 
mucus hypersecretion in the airways of rats was stimulated 
(Borchers et al�, 1998)� The formaldehyde concentrations 
in the smoke inhalation studies (<0�5 mg/m3) were below 
the  lowest  observed  effect  level  observed  in  the  sub-
chronic formaldehyde inhalation study (Woutersen et al�, 
1987) and below thresholds considered to be relevant for 
genotoxic and carcinogenic effects (Nielsen and Wolkoff, 
2010)� At no-toxic effect levels, neither additive nor poten-
tiating effects occurred from the combined exposure to 
these aldehydes (Cassee et al�, 1996)� In principle, the lack 
of additive or potentiating effects in defined mixtures of 
aldehydes does not exclude an additive or potentiating 
effect by the increased aldehyde levels on the background 
of smoke-related findings seen in these inhalation stud-
ies, but such effect was not observed� Thus, the totality 
of the reviewed studies suggests that the increased alde-
hyde yields determined in the chemical analyses did not 
increase the activity of the smoke in toxicological assays 
that are in principle sensitive to their activity� Moreover, 
the overall changes by the use of sugars as ingredients 
determined  in  the  chemical  analyses  may  either  have 
balanced each other out or were not large enough to sig-
nificantly affect the toxicological activity that is inherent 
to cigarette smoke in the assays employed�
7.  Comparison of marketed American-blend 
and Virginia-type cigarettes
The above non-clinical studies should ideally be compli-
mented by clinical and epidemiological data on exposure 
and  effects  differentiating  between  smokers  smoking 
cigarette types with and without sugars used as tobacco 
ingredients� However, such data for a direct comparison 
of commercial cigarette types that differ by only this one 
parameter are not available, with the exception of menthol 
versus non-menthol cigarettes (Werley et al�, 2006; Heck, 
2010)� As a substitute, we compared data from markets 
of primarily American-blend and Virginia-type cigarette 
consumption, respectively� These cigarette types differ in 
their blend composition, but also in their natural sugar 
content and the level of sugar applied as ingredient�
7.1.  Relative impact of sugar application on chemical 
composition of mainstream smoke in marketed 
American-blend and Virginia-type cigarettes
The chemical composition of mainstream smoke gener-
ated from American-blend and Virginia-type cigarettes 
is  qualitatively  similar,  with  some  quantitative  differ-
ences,  most  of  which  can  be  explained  by  the  differ-
ences in tobacco blend composition� For instance, the 
higher  yields  of  nitrogen-containing  smoke  constitu-
ents  observed  for  single-blend  Burley  compared  with 
single-blend  Virginia  research  cigarettes  (Adam  et  al�, 
2006; Ding et al�, 2008) carries over to American-blend 
compared  to  Virginia-type  cigarettes,  in  particular 
resulting in higher yields of most of the tobacco-specific 
N-nitrosamines,  nitrogen  oxides,  ammonia,  and  aro-
matic amines in American-blend cigarettes (Gregg et al�, 
2004; Counts et al�, 2005; Hyodo et al�, 2007; Hammond 
and O’Connor, 2008)� High molecular weight polycyclic 
aromatic  hydrocarbons,  such  as  benzo[a]pyrene  and 
benzo[k]fluoranthene, are formed at lower yields in the 
mainstream smoke of single-blend Burley than in that 
of Virginia research cigarettes (Ding et al�, 2008), which 
also carries through to mostly lower yields in American-
blend compared to Virginia-type market cigarettes (Ding 
et al�, 2006)� This difference has been related to the higher 
nitrate  content  in  Burley-containing  cigarettes,  which 
may interfere with the pyrolytic formation of polycyclic 
aromatic hydrocarbons� Formaldehyde yields are gener-
ally lower in the smoke of American-blend than in that of 
Virginia-type cigarettes, which is considered to be related 
to the lower overall sugar content and higher levels of 
nitrogen-containing  compounds  (Leffingwell,  1999)  in 
American-blend compared to Virginia-type cigarettes�
The pooled chemical analyses of the mainstream smoke 
of research cigarettes as described above suggested that 
there are statistically significant increases in the slopes of 
the linear regressions in the nicotine-based yields of seven 
smoke  constituents  with  increasing  sugar  application 
levels, most importantly for formaldehyde, benzene, and 
acrolein� The increased yields were mainly observed using 
research cigarettes with sugar application levels beyond 
the maximum application level of 5% used in commer-
cial cigarettes� Consequently, marketed American-blend 
cigarettes, which do not have a higher total sugar con-
tent than marketed Virginia-type cigarette, do not show 
an increased yield of these smoke constituents in direct 
comparisons (Table 8)� Rather, the nicotine-based yield of 
formaldehyde from American-blend cigarettes is on aver-
age 20–40% lower than that from Virginia-type cigarettes, 
independent of the machine-smoking condition used for 
the smoke generation� For acrolein, 2-butanone, benzene, 
and  toluene,  no  relevant  differences  in  nicotine-based 
yields were found when comparing American-blend and 
Virginia-type  market  cigarettes�  Benzo[k]fluoranthene, 
the one polycyclic aromatic hydrocarbon with statistically 
significant increased yield in the pooled analysis, has not 
been determined in market benchmarking studies with 
one exception, in which on average 27% lower yields were 
determined for American-blend compared to Virginia-type 
cigarettes (Ding et al�, 2006)� This agrees with the findings 
of numerically lower nicotine-based yields for benzo[a]
pyrene, which is mostly determined as the only representa-
tive of this class of constituents, for   American-blend versus 266  E. Roemer et al.
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Virginia-type market cigarettes (Table 8)� Thus, the use of 
sugars as ingredients may not cause any concerns regard-
ing this class of smoke constituents� As mentioned above, 
the largest difference in the composition of the smoke gen-
erated  from  American-blend  or  Virginia-type  cigarettes 
stems from nitrogen-containing compounds (Table 6)� Of 
these, nicotine-based yields of N-nitrosodimethylamine, 
N-nitrosonornicotine, and 4-aminobiphenyl were found to 
decrease in a statistically significant manner with increas-
ing sugar application levels in the pooled analysis� Taken 
together, those constituents found to significantly increase 
in research cigarettes with increasing sugar application 
levels were similar or even lower in American-blend than 
in Virginia-type market cigarettes, whereas the use of sug-
ars as tobacco ingredients in American-blend cigarettes 
attenuates the yields of some of those constituents which 
are  high  in  American-blend  compared  to  Virginia-type 
market cigarettes�
In summary, in American-blend compared to Virginia-
type cigarettes, parts of the Virginia tobacco are replaced 
by  Burley  tobacco,  which  is  practically  free  of  sugars� 
The resulting decrease in the natural sugar content in 
the  blend  is  partly  replenished  by  applying  sugars  as 
ingredients to levels at or below that found in Virginia-
type  cigarettes�  Thus,  the  sugar-dependent  findings  in 
the  pooled  analysis  of  smoke  constituent  yields  from 
research cigarettes do not carry over to increased yields 
of these constituents in the blended cigarettes compared 
to  Virginia-type  cigarettes�  For  instance,  the  observed 
increases in formaldehyde, acrolein, or benzene by sugar 
application to research cigarettes do not result in higher 
average yields of these constituents in American-blend 
compared to Virginia-type cigarettes� On the contrary, 
formaldehyde  yields  tend  to  be  higher  on  average  in 
Virginia-type cigarettes� The sugar-dependent decreased 
yields of some nitrogen-containing smoke constituents 
seen  in  the  pooled  analysis  of  the  research  cigarettes 
alleviate the naturally higher yields of these constituents 
in the smoke from Burley-containing cigarettes�
7.2.  Comparison of marketed American-blend and 
Virginia-type cigarettes in toxicological assays
The comparative activity of American-blend and Virginia-
type cigarettes was assessed in in vitro cytotoxicity and 
Table 8.  Selected mainstream smoke constituent yields (per mg nicotine) for marketed American–blend and Virginia–type cigarettes 
(Counts et al., 2005; Gregg et al., 2004; Hammond and O’Connor, 2008).
Constituent
Yields (M ± SD) (mg nicotine)−1
Reference
ISO smoking conditions HCI smoking conditions
American– 
blend
Virginia– 
type
Difference§  
(%)
American– 
blend
Virginia– 
type
Difference§  
(%)
Formaldehyde (µg) 45 81 – 44 46 76 – 39 Hammond
  31 ± 12 40 ± 14 – 21 39 ± 13 68 ± 23 – 42 Counts
  28 ± 12 34 ± 16 – 18       Gregg
Acetaldehyde (µg) 641 656 – 2 615 513 + 20 Hammond
  578 ± 122 589 ± 111 – 2 686 ± 163 652 ± 159 + 5 Counts
  673 ± 123 820 ± 123 – 18       Gregg
Acrolein (µg) 63 80 – 21 65 67 – 3 Hammond
  52 ± 12 53 ± 5 – 2 68 ± 16 67 ± 18 + 0 Counts
  58 ± 11 68 ± 16 – 15       Gregg
2–Butanone (µg) 68 ± 15 74 ± 17 – 8 92 ± 21 93 ± 19 – 1 Counts
  74 ± 14 95 ± 14 – 22       Gregg
Benzene (µg) 47 51 – 8 41 37 + 11 Hammond
  51 ± 10 51 ± 17 + 0 39 ± 8 39 ± 5 + 0 Counts
  52 ± 9 58 ± 8 – 10       Gregg
Toluene (µg) 76 78 – 3 74 65 + 14 Hammond
  74 ± 14 71 ± 18 + 4 72 ± 15 65 ± 9 + 10 Counts
  85 ± 14 92 ± 16 – 7       Gregg
Benzo[a]pyrene (ng) 7.9 13.1 – 40 7.3 10.0 – 27 Hammond
  11.5 ± 3.0 10.8 ± 1.2 + 6 8.8 ± 2.2 10.3 ± 2.7 – 15 Counts
  12.0 ± 1.0 15.8 ± 1.8 – 24       Gregg
N–Nitrosonornicotine (ng) 187 28 +567 161 22 +632 Hammond
  149 ± 78 25 ± 6 +496 108 ± 47 17 ± 0 +538 Counts
  94 ± 16 53 ± 34 + 76       Gregg
4–Aminobiphenyl (ng) 2.4 1.9 + 26 2.1 1.5 + 40 Hammond
  3.1 ± 0.8 2.1 ± 0.9 + 50 2.2 ± 0.5 1.3 ± 0.1 + 73 Counts
  1.4 ± 0.3 1.2 ± 0.4 + 17       Gregg
Smoking conditions: ISO: International Standardization Organization; HCI: Health Canada Intense.
§Difference of nicotine–based yields of American–blend vs. Virginia–type cigarettes;
Bold print: statistically significant difference between both types of cigarettes (not available for Hammond dataset for nicotine–based 
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genotoxicity  assays,  mostly  by  using  the  mainstream 
smoke of reference cigarettes representative of the two 
types  of  market  cigarettes�  Smoke  from  Virginia-type 
cigarettes was consistently more cytotoxic than that of 
American-blend cigarettes (Bombick et al�, 1998; Roemer 
et al�, 2004; Rickert et al�, 2007a)� This was true for the 
particulate and the gas/vapor phase, which were inves-
tigated in two of the studies� These results are consistent 
with the tendency to higher cytotoxicity of Virginia com-
pared to Burley single-blend research cigarettes (Pickett 
et al�, 2010), while in a larger inter-laboratory study on 
the cytotoxicity of the particulate phase on average no 
such differences were found (Pickett et al�, 2010)�
In the Salmonella reverse mutation assay, mainstream 
smoke condensate from American-blend cigarettes was 
consistently  more  mutagenic  than  the  condensate  of 
Virginia-type cigarettes (Mizusaki et al�, 1977; Roemer 
et al�, 2004; Rickert et al�, 2007a)� This result is consis-
tent with the higher mutagenicity of smoke from Burley 
tobacco  compared  with  that  from  Virginia  tobacco 
(Mizusaki  et  al�,  1977;  Yoshida  and  Matsumoto,  1980; 
Gairola, 1982; Clapp et al�, 1999; DeMarini et al�, 2008)� In 
mammalian cell-based genotoxicity assays, in contrast to 
the bacterial assay and depending on the specific assay 
type used (and on the laboratory conducting the assay), 
particulate  matter  from  single-blend  Burley  mostly 
tended to be less active than that from Virginia cigarettes 
(Schramke et al�, 2006; DeMarini et al�, 2008)�
In  subchronic  inhalation  studies,  the  smoke  from 
Virginia-type cigarettes seemed to have higher potency 
than  that  of  single-blend  Burley  or  American-blend 
cigarettes  regarding  histopathological  changes  in  the 
larynx  (compiled  by  Smith,  1990)�  Histopathological 
findings in the trachea and lungs were of similar degree� 
Dermal carcinogenicity studies in mice were not able to 
clearly differentiate between the condensates generated 
from  American-blend  and  single-blend  Virginia  and 
Burley research cigarettes� If anything, there was a trend 
towards slightly higher tumorigenic potency for Virginia 
than Burley condensate, with that of the American-blend 
cigarettes  being  somewhat  intermediate  (Wynder  and 
Hoffmann, 1963; Dontenwill et al�, 1976; US Department 
of Health Education and Welfare, 1980)�
The comparison of the market cigarette types indicates 
that  the  differences  in  toxicity  observed  between  the 
smoke of Virginia-type and American-blend cigarettes 
appear to reflect the toxicity of the tobacco blend com-
ponents rather than the application of sugar�
Current scientific knowledge does not allow a con-
clusion  about  which  of  these  assay  types  or  particu-
lar  endpoints  are  more  predictive  of  the  induction  of 
smoking-related diseases in humans� In summary, the 
results of the toxicological assays on research and market 
cigarettes confirm that cigarette smoke is toxic; however, 
they also suggest that the use of sugars applied to the 
tobacco of American-blend cigarettes at current use lev-
els is unlikely to increase the inherent toxicity of tobacco 
smoke�
7.3.  Simulated uptake in smokers of mainstream 
smoke constituents at maximum sugar application 
level and from marketed American-blend and  
Virginia-type cigarettes
In order to further evaluate the changes in mainstream 
smoke  chemistry  that  were  determined  in  the  pooled 
analysis  described  above  as  a  consequence  of  using 
sugars as cigarette tobacco ingredients, a simulation of 
the differential smoking-related exposure to those con-
stituents was performed, for which statistically significant 
quantitative changes were identified� This approach offers 
the most discriminatory analysis of potential changes in 
mainstream  smoke  exposure  resulting  from  the  use  of 
a particular ingredient in a research cigarette, but it has 
some limitations with regard to the extrapolation of the 
results to market cigarettes and their actual use by con-
sumers� Therefore, the hypothetical changes in exposure 
to particular constituents from research cigarettes at 0 and 
5% were simulated and compared to those from average 
American-blend and Virginia-type market cigarettes�
Most information on exposure and uptake of cigarette 
smoke constituents has been generated for nicotine via 
the  determination  of  nicotine  and  some  of  its  major 
metabolites in human body fluids, such as saliva, plasma, 
or urine� If trans-3′-hydroxycotinine, cotinine, and nico-
tine are determined together with their glucuronide con-
jugates, approximately 80–95% of the nicotine uptake may 
robustly be determined in terms of “nicotine equivalents,” 
eliminating much of the effect of inter-individual meta-
bolic differences (Tricker, 2006)� Assuming proportional 
relationships between the yields of nicotine and most 
other  constituents  (Roemer  et  al�,  2004;  Counts  et  al�, 
2005; Hyodo et al�, 2007; King et al�, 2007), the uptake of 
these  constituents  and  their  distribution  among  indi-
vidual smokers can be predicted by bridging from known 
nicotine uptake distributions� Such uptake distributions 
offer a more informed estimate of the impact of potential 
changes in smoke composition than just point estimates 
for nicotine uptake� Using Monte Carlo simulation, the 
mean  and  standard  deviation  of  nicotine  equivalents 
determined  in  a  German  population-based  biomoni-
toring  study  with  American-blend  cigarettes  (Scherer 
et al�, 2007) was connected with the mean and standard 
deviation  of  the  nicotine-based  yields  for  the  respec-
tive  constituents  at  the  0  or  5%  sugar  addition  levels, 
respectively, as determined in the pooled analysis� This 
approach enables calculation of uptake distributions per 
cigarette which provide insight beyond the simple results 
of  standard  machine-smoking  conditions  and  incor-
porates  the  variability  of  human  smoking  behavior  as 
best as possible� This variability is reflected in the broad 
distribution of the uptake of nicotine equivalents after 
Monte Carlo simulation (Figure 6) and propagates to the 
distribution simulated for any of the other constituents� 
A log-normal model was used for the simulation, which 
seems to be justified in view of more recent and more 
detailed distribution data on nicotine uptake (Mendes 268  E. Roemer et al.
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et al�, 2009), although higher modes for the distributions 
were obtained than in the current simulation� The same 
simulation  was  applied  to  the  average  nicotine-based 
yields of smoke constituents of the market cigarettes�
The distributions calculated for acrolein uptake from 
smoking  hypothetical  research  cigarettes  at  0  and  5% 
sugar application level as well as that from the average 
yield data of American-blend and Virginia-type cigarettes 
almost completely overlap (94% of the distribution at 5% 
sugar application level coincides with the distribution at 
no sugar application; Figure 7)� Nevertheless, the modes 
of  these  distribution  curves  reflect  the  small  differ-
ences in nicotine-based acrolein yields calculated from 
machine-smoking of the respective research and market 
cigarettes (Tables 3 and 8), i�e� a slight increase from 0 to 
5% sugar application level but a smaller simulated uptake 
from American-blend vs� Virginia-type market cigarettes� 
For the validation of this approach, the simulations for 
acrolein uptake were compared with the acrolein yields 
of  market  cigarettes  (Counts  et  al�,  2005)  if  machine-
smoked at three standardized conditions (International 
Organization  for  Standardization,  1991;  Massachusetts 
General Laws Annotated, 1997; Health Canada, 2000)� 
This is possible since practically all nicotine and acrolein 
inhaled from smoking are absorbed (Baker and Dixon, 
2006)� The median acrolein uptake per cigarette deter-
mined by the simulation is similar to the average yield 
obtained when this selection of cigarettes was smoked 
under intermediately intense conditions (Massachusetts 
General  Laws  Annotated,  1997)�  This  similarity  is  rea-
sonable as in a recent review on actual human smoking 
conditions  (Bernstein,  2004),  median  values  for  inter-
puff interval, puff duration, and puff volume of 28 s, 1�9 s, 
and 43 ml, respectively, were found to be very close to 
the respective values under these intermediate machine-
smoking conditions (30 s, 2 s, and 45 ml)�
The uptake distributions for benzene (Figure 8A), tolu-
ene, benzo[k]fluoranthene, and NDMA also overlapped 
to a very large degree indicating no relevant difference 
by  sugar  application  and  market  type  cigarette�  Uptake 
Figure  6.  Monte  Carlo  simulation  of  the  nicotine  uptake 
distribution  based  on  nicotine  equivalents  from  a  population-
based  biomonitoring  study  with  smokers  of  American-blend 
cigarettes.  Data  from  (Scherer  et  al.,  2007),  corrected  for  85% 
recovery of nicotine and its metabolites; log-normal Monte Carlo 
simulation; blue line: forecast values; magenta line: fitted line 
(mode: 0.52 mg/cig.; median: 1.03 mg/cig.).
Figure 7.  Simulation of acrolein uptake distributions for research cigarettes with 0 and 5% sugar application and American-blend and 
Virginia-type market cigarettes (right panel) in comparison to acrolein yields obtained by three machine-smoking conditions (left panel, 
reproduced with permission; Counts et al., 2005). Machine-smoking data compared to the fitted log-normal Monte Carlo simulation 
of  acrolein  uptake  using  Crystal  Ball;  left  panel:  ○:  ISO  smoking  conditions  (International  Organization  for  Standardization,  1991),   
▴: Massachusetts smoking conditions (Massachusetts General Laws Annotated, 1997), □: Health Canada smoking conditions (Health 
Canada, 2000); right panel: blue line: research cigarettes with 0% sugar addition; red line: research cigarettes with 5% sugar application; 
green line: American-blend market cigarettes, violet line: Virginia-type market cigarettes.Sugars as cigarette ingredients  269
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distributions per cigarette are also shown for formaldehyde 
(Figure 8B) and 4-aminobiphenyl (Figure 8C) representing 
smoke constituents with the largest percentage increases 
or decreases in nicotine-based yields with increasing sugar 
application levels� The hypothetical formaldehyde uptake 
increased by sugar application to the research cigarettes 
(overlap of 86%), but this increase was still smaller than 
the increase from American-blend to Virginia-type market 
cigarettes�  The  hypothetical  uptake  of  4-aminobiphenyl 
was higher for American-blend than for Virginia-type cig-
arettes, while it got smaller with sugar application� Thus, 
the uptake simulations reflect the changes in the point 
values determined in the pooled analysis of the research 
cigarettes or the differences in the average yield data of the 
market cigarettes, but these changes and differences are 
put into the perspective of the broad inter-individual vari-
ability in the uptake of these constituents by smokers�
In a recent benchmark study for biomarkers of exposure 
to smoke constituents, groups of smokers from Germany 
and  the  UK  as  prototypic  markets  of  American-blend 
and  Virginia-type  cigarettes  were  compared  (Lindner 
et  al�,  2011)�  Smoking-attributable  excretion  levels  of 
3′-hydroxypropyl-mercapturic acid, a urinary acrolein-
related  biomarker  of  exposure,  were  1�19  and  1�13 mg 
per 24 h for German and the UK smokers, respectively, 
with relative standard deviations of approximately 100% 
(and on a nonsmoking background of approximately one 
third of the smokers’ levels)� For S-phenylmercapturic 
acid,  a  marker  for  benzene  exposure,  urinary  marker 
levels were 3�8 and 3�6 µg per 24 h German and UK smok-
ers, respectively, while those for 4-aminobiphenyl were 
26 and 21 ng per 24 h� Thus, the biomarker data confirm 
the similarity of exposures to these constituents on the 
basis of means and standard deviations (as a measure 
of variance) by the two types of cigarettes as suggested 
by the current modeling approach based on analytical-
chemical data� The authors concluded that the contribu-
tion of the country and thus the type of cigarettes smoked 
to the total variation was marginal for all biomarkers of 
exposure investigated (Lindner et al�, 2011)�
7.4.  Comparison of American-blend and Virginia-type 
markets regarding smoking behavior
The above approach of bridging from the uptake of nico-
tine to that of other smoke constituents is only reason-
able as a determinant of potential changes of exposure 
by the use of sugars as ingredients, if there is no change 
in smoking behavior to be expected� There are no stud-
ies available that have assessed the potential direct effect 
of  using  sugars  as  ingredients  on  smoking  behavior� 
However, studies on “exotically” flavored cigarettes did 
not reveal any difference in smoking behavior compared 
to regular American-blend cigarettes (O’Connor et al�, 
2007),  nor  have  there  been  differences  in  exposures 
between smokers of mentholated and non-mentholated 
cigarettes (Heck, 2009; Wang et al�, 2010)� Thus, it is not 
expected that there would be any difference in overall 
smoke exposure from using sugars as ingredients�
This  interpretation  is  further  corroborated  by  the 
lack of differences for nicotine uptake per cigarette from 
smokers  from  various  regions  of  the  world  including 
those  of  predominantly  American-blend  and  Virginia-
type markets, which among other parameters differ by 
the use of sugars as ingredients (Figure 9A)� The intake 
of nicotine per cigarette was also considered to be simi-
lar in a study that included smokers from Brazil, Mexico, 
China, and Poland (Blackford et al�, 2006)� A most recent 
international comparison determined nicotine exposure 
(“mouth level exposure,” MLE) based on nicotine residues 
in the filters of smoked cigarettes collected in eight coun-
tries (Mariner et al�, 2011)� No differences between those 
countries for MLE in dependence of the ISO nicotine yield 
of the cigarettes smoked were seen (Figure 9B)� However, 
when the cigarettes across the countries were separated 
into Virginia- and American-blend types, overall MLEs 
Figure  8.  Simulation  of  benzene  (A),  formaldehyde  (B),  and 
4-aminobiphenyl (C) uptake distributions for research cigarettes 
with 0 and 5% sugar application and American-blend and Virginia-
type market cigarettes. For color legend, see explanations for the 
right panel in Figure 7.270  E. Roemer et al.
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for smokers of Virginia-type cigarettes were significantly 
greater than those of American-blend smokers, reflecting 
differences (and preferences) in ISO yields� After adjusting 
the MLE data for the differences in ISO yields, the nicotine 
(and tar) MLEs per cigarette were higher for the American-
blend than the Virginia-type smokers� Thus, no clear trend 
that could be related to the use of sugars as ingredients 
could be observed either� Such an ecological approach 
of  comparing  markets  has  also  been  chosen  by  the 
International Tobacco Control Policy Evaluation Survey 
(Hammond et al�, 2004) and others (International Agency 
for  Research  on  Cancer,  2007;  European  Commission 
Health  and  Consumer  Protection  Directorate-General 
Scientific Committee on Emerging and Newly Identified 
Health Risks, 2008) in order to deduce potential determin-
ing principles and trends in tobacco exposure and related 
diseases from the comparison of national data�
Further variables of smoking behavior in a popula-
tion  are  smoking  prevalence  and  intensity�  Smoking 
prevalence data have been published by many national 
and international sources� Data published by the World 
Health Organization demonstrate wide international dif-
ferences in smoking prevalence (MacKay and Eriksen, 
2002; World Health Organization, 2008), but do not indi-
cate trends by the predominant type of cigarette smoked 
in a particular country (Figure 10)� In an extensive study 
Figure  9.  Survey  of  nicotine  uptake  estimates  per  cigarette  in 
smokers  (mg/cig.).  A:  Estimated  nicotine  uptake  from  plasma, 
urine (based on nicotine equivalents for plasma and urine), or 
cigarette  filter  analyses  (mouth  level  exposure).  Cigarettes  of 
American-blend (Byrd et al., 1998; Gori and Lynch, 1985; Mendes 
et al., 2009; Scherer et al., 2007; Shepperd et al., 2009; St Charles 
et al., 2010), Virginia-type (Jarvis et al., 2001), or unknown nature 
(Ueda et al., 2002) were smoked in these studies. B: Estimated 
nicotine uptake determined as “mouth level exposure” based on 
cigarette filter analyses in eight different countries with varying 
blend preferences (reproduced with permission; Mariner et al., 
2011).
Figure  10.  Smoking  prevalences  in  American-blend  and 
Virginia-type  cigarette  markets.  Data  from  American-blend 
(United States, Germany, and France) and Virginia-type markets 
(United Kingdom, Australia, and Canada) (MacKay and Eriksen, 
2002; World Health Organization, 2008: data from approximately 
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comparing exposure and chronic disease risk between 
countries  with  predominant  American-blend  (United 
States,  Germany,  Austria,  and  Denmark)  and  coun-
tries  with  predominant  Virginia-type  smokers  (United 
Kingdom, Australia, and Canada), stratified by age group, 
gender, and time periods from 1971 to 2000, no overall 
statistically significant difference in smoking prevalence 
could  be  detected  (Lee  et  al�,  2009)�  The  ex-smoking 
prevalence was generally increasing over the time peri-
ods investigated in both sexes and all age groups and 
was  lower  in  American-blend  than  Virginia-type  mar-
kets,  although  only  rarely  with  statistical  significance� 
The International Tobacco Control (ITC) Four Country 
Survey investigated quit rates and cessation in Australia, 
Canada,  the  United  Kingdom,  and  the  United  States 
(Hyland et al�, 2006)� They concluded that predictors of 
making quit attempts and cessation were similar for each 
of the four countries� Although there were some differ-
ences among the countries in predictors of success, such 
as heaviness of smoking index, favorable attitudes about 
smoking, and self-efficacy, these differences could not be 
associated with American-blend or Virginia-type prefer-
ences in these countries�
The most frequent measure of smoking intensity is the 
number of cigarettes smoked per day� For this variable 
over all time periods and age groups, no difference was 
observed  between  American-blend  and  Virginia-type 
markets,  while  smoking  intensity  was  higher  in  males 
than in females (approximately 20 vs� 16 cigarettes per 
day) (Lee et al�, 2009)� This gender difference in smoking 
intensity and the lack of difference between American-
blend and Virginia-type markets (Figure 11) can also be 
derived from data from the International Tobacco Control 
Policy Evaluation Survey (Hammond et al�, 2004; Hyland 
et al�, 2006)� In an international comparison, England as 
a predominantly Virginia-type market had intermediate 
scores in the Fagerström Test for Nicotine Dependence, 
while Germany and the United States as predominantly 
American-blend markets showed the most extreme dif-
ferences (Fagerström and Furberg, 2008)� Those scores 
were  inversely  related  to  smoking  prevalence  rates  in 
these countries, which again puts the Virginia-type mar-
ket into the range observed for American-blend markets� 
Likewise,  no  distinction  could  be  made  for  a  number 
of  smoking  dependence-related  parameters,  includ-
ing smoking intensity, heaviness of smoking index, and 
number and duration of quit attempts, between smokers 
from American-blend and Virginia-type markets (Shahab 
et al�, 2008)�
Summarizing  the  data  detailed  above,  there  are  no 
indications that the use of sugars as ingredients, which 
is  one  characteristic  of  American-blend  cigarettes, 
has any influence on smoking behavior and behavior-
related  exposure,  either  in  terms  of  cigarette  smoking 
prevalence,  the  frequency  of  quit  attempts,  smoking 
intensity as cigarettes per day, and nicotine uptake� In 
addition, these data do not in any case support the sug-
gestion that the use of sugars as ingredients or any other 
ingredients in American-blend cigarettes would lead to 
an increased dependence potency by whatever mecha-
nism hypothesized�
7.5.  Comparison of American-blend and  
Virginia-type markets regarding smoking-related 
disease risks
Predominantly  American-blend  and  Virginia-type 
markets were compared for the risks of mortality from 
smoking-related  lung  cancer  and  COPD  (Lee  et  al�, 
2009), two major serious diseases that can be caused by 
chronic smoking� Unadjusted mortality rates were gener-
ally lower early on in markets with predominant Virginia-
type  cigarettes,  with  the  difference  diminishing  or 
reversing by the 1990s� Differences by cigarette type were 
rarely significant for age and time period groupings, due 
to variations, particularly for COPD, between countries 
within cigarette type� Conclusions based on estimated 
smoking-related excess mortality were similar to those 
based on unadjusted mortality rates: There was little indi-
cation of any difference between American-blend and 
Virginia-type cigarettes on risk of lung cancer or COPD� 
The approach of this study had of course less discrimina-
tive power than any analytical-chemical study, which is 
partly due to unspecified differences between countries 
with the same type of predominant cigarette type� It was 
estimated that this study could have detected differences 
of 25–40% for male lung cancer, or twofold differences for 
females or for COPD, had they existed� This is similar to 
the discriminatory power of many subchronic laboratory 
animal inhalation studies�
Figure  11.  Daily  cigarette  consumption  in  predominantly 
American-blend  (United  States)  and  Virginia-type  (United 
Kingdom/England, Canada, Australia) markets for male (hatched 
bars) and female (dotted bars) smokers. Data of the years 2000–
2002 taken from International Tobacco Control Policy Evaluation 
Survey (Hammond et al., 2004): ITCPES: International Tobacco 
Control Policy Evaluation Survey; NHIS: National Health Interview 
Survey; GHS: General Household Survey; HSE: Health Survey for 
England;  CTUMS:  Canadian  Tobacco  Use  Monitoring  Survey; 
CCHS:  Canadian  Community  Health  Survey;  NTCES:  National 
Tobacco  Survey  Evaluation  Campaign;  NDDS:  National  Drug 
Strategy Household Survey.272  E. Roemer et al.
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7.6.  Conclusion, comparison of marketed cigarettes
With the most discriminatory non-clinical endpoints for 
the evaluation of mainstream smoke, such as chemical 
analysis or in vitro assays, differences in both directions 
can be detected between American-blend and Virginia-
type market cigarettes� With the current state of knowl-
edge, it is not clear which of these endpoints would be 
more relevant than others in predicting human health 
issues� No relevant difference between American-blend 
and  Virginia-type  cigarettes  was  detected  for  smoke 
exposure  and  effects,  including  measures  for  smoking 
dependence  and  smoking-related  chronic  diseases� 
Thus, with the current means of investigation of these 
endpoints, there is no indication of any relevant effect of 
using sugars as ingredient in commercial cigarettes�
8.  Limitations and uncertainties of  
this assessment
The current assessment is considered a comprehensive 
evaluation  of  the  evidence  available  on  the  potential 
effects of using sugars as ingredients� However, no such 
assessment can be without limitations, because cigarette 
smoke is a complex mixture of constituents and smoking-
related  diseases  have  complex  chronic  pathogeneses� 
Nevertheless, the scope of the current assessment went 
beyond  standard  ingredient  assessments  by  industry 
or  regulatory  authorities,  e�g�  by  modeling  changes  in 
smoke chemistry observed with research cigarettes into 
uptake distributions for smokers or by evaluating changes 
observed with research cigarettes in comparison to dif-
ferences  between  principle  types  of  market  cigarettes, 
which  included  the  possibility  of  indirectly  assessing 
smoking behavior�
There are areas for which appropriate studies are miss-
ing and for practical reasons will continue to be missing� 
One example is the lack of a direct comparison of smok-
ers smoking American-blend cigarettes with and without 
sugars applied as ingredients for the evaluation of a poten-
tial impact on smoking prevalence, smoke exposure, and 
smoking-related  biological  effects�  An  American-blend 
cigarette is defined by using sugars as ingredients, and 
the combustion products of these sugars in the tobacco 
matrix contribute to the overall flavor of such cigarettes 
thus  enhancing  the  natural  taste  characteristics  of  the 
tobacco� A hypothetical clinical study comparing smoke 
exposure  from  cigarettes  with  and  without  sugars  as 
ingredients  would  intrinsically  be  confounded  by  the 
uncommon taste of the test cigarettes without sugar� In 
order to assess this question in a more indirect manner, 
the  best  opportunity  was  considered  to  be  a  compari-
son  of  markets  with  smokers  predominantly  smoking 
American-blend cigarettes with added sugars and those 
predominantly smoking Virginia-type cigarettes without 
added sugars� However, these two types of cigarettes also 
differ in their natural content of sugars, resulting in simi-
lar or even lower overall sugar content in American-blend 
cigarettes compared to Virginia-type cigarettes�
There has been a broad agreement for the selection 
of smoke constituents or in vitro assays considered to 
be  appropriate  for  such  assessments  between  indus-
trial  and  independent  laboratories  as  well  as  the  few 
emerging regulations (e�g� Health Canada, 2000; Gregg 
et al�, 2004; Counts et al�, 2005; Brazil National Health 
Monitoring Agency, 2007; Hyodo et al�, 2007; Hammond 
and O’Connor, 2008; Moir et al�, 2008; Gaworski et al�, 
2009), although most recently larger selections of smoke 
constituents have been suggested (Talhout et al�, 2011; 
US Food and Drug Administration, 2011)� The constitu-
ents  considered  most  important  by  the  World  Health 
Organization  Working  Group  on  Tobacco  Regulation 
(Burns  et  al�,  2008;  World  Health  Organization  Study 
Group  on  Tobacco  Product  Regulation,  2008)  were 
of  course  all  included  in  the  current  assessment� 
Nevertheless,  only  a  selection  of  constituents  or  toxi-
cological activities is being assessed, assuming that the 
results of the selected endpoints would be representa-
tive  of  other  constituents  and  biological  endpoints� 
In  order  to  increase  the  relevance  of  the  non-clinical 
toxicological testing, subchronic inhalation studies have 
been  included  for  the  assessment  of  major  cigarette 
ingredients, such as for sugars� A comprehensive array 
of  potential  target  organs  and  tissues  has  often  been 
included in the evaluation of these inhalation studies (in 
line with Organization for Economic Co-operation and 
Development,  2009)  including,  e�g�  cardiovascular  or 
reproductive organs, in order to minimize the probabil-
ity of increasing the risks for the various smoking-related 
diseases and to avoid any new risks�
The non-clinical assay types reviewed here have been 
taken over from those used in other areas of regulatory 
toxicology� While their suitability for assessing the toxic-
ity of smoke has not finally been established, this is not 
specifically the objective of cigarette ingredient testing 
anyhow�  The  objective  is  rather  to  determine  that  no 
significant toxicity is added to that intrinsic to tobacco 
smoke, either of the same type or new� Thus, classic regu-
latory toxicity tests may fit well to the testing of cigarette 
ingredients,  if  appropriately  adapted  to  deal  with  the 
intrinsic toxicity of smoke and the resulting need for com-
parative testing� The bacterial mutagenicity assay may 
not be the optimal tool to evaluate the genotoxic prop-
erty of smoke per se, but it may serve appropriately for the 
detecting of potential changes in genotoxic potency of 
smoke samples� For the testing of ingredients, the assay 
has been adapted to describe a linear dose-response rela-
tionship with smoke TPM, and the slope obtained with 
the test samples generated from experimental cigarettes 
with various ingredient application levels is compared in 
a quantitative manner (Roemer et al�, 2002)� The in vitro 
cytotoxicity assay has proven to be particularly useful for 
the assessment of cigarette smoke, as it relates to the irri-
tative potency of smoke seen in in vivo studies� In in vitro 
genotoxicity studies with smoke, cytotoxicity has always 
been a limiting factor for dosing and interpretation thus 
demonstrating the relevance of this particular activity in Sugars as cigarette ingredients  273
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assessing the complex toxicity of smoke� Finally, for the 
assessment of ingredients with relatively high applica-
tion levels, subchronic inhalation studies have been used 
that have also been adapted to the comparative testing 
paradigm in terms of dosing and endpoint selection in 
order to study the relationship of the ingredient applica-
tion level to the respective endpoints�
Uncertainties  in  the  current  assessment  are  also 
related to the limits in discriminatory power due to data 
variability in the studies underlying this assessment� The 
minimal  detectable  difference  (as  a  measure  for  dis-
criminatory power) in smoke chemistry, bacterial muta-
genicity, and in vitro cytotoxicity has been determined 
to range between <10 and 30% of the mean responses 
assuming  a  significance  level  of  0�05  (α)  and  a  type 
two error of 20% (β) (Roemer et al�, 2010)� Limitations 
in discriminatory power are particularly relevant when 
evaluating studies with a comparative design trying to 
detect  differences  against  a  control  group  with  more 
or less the same qualitative chemical composition and 
a  pronounced  activity  in  the  biological  tests�  In  turn, 
this  shows  that  the  major  contribution  to  toxicologi-
cal potency, if not all, is indeed related to the intrinsic 
properties of cigarette smoke and not to the presence 
or absence of ingredients� Limitations in scope and dis-
criminatory power and the uncertainty in interpreting 
effects seen in a particular study can at least be partially 
overcome by combining an array of assays with different 
but complementary information�
Finally,  as  with  most  comprehensive  compara-
tive  assessments  including  a  plethora  of  studies  and 
endpoints,  there  are  changes  in  individual  endpoints 
pointing in both directions� There are endpoints, which 
change in a potentially favorable direction, e�g� the in 
vitro cytotoxicity of the particulate fraction or the yields of 
some N-nitrosamines, which have been implicated with 
smoking-related carcinogenicity� There are also changes 
in a potentially adverse direction, e�g� the yields of form-
aldehyde and benzene, which also have been implicated 
with smoking-related carcinogenicity�
Within the limitations of this assessment, the overall 
evidence does not suggest an increased risk or harm 
by using sugars as cigarette tobacco ingredients� Vice 
versa, these same limitations also hold true if one would 
consider omitting the use of sugars as ingredients in 
currently marketed cigarettes and replace it by tobacco 
instead� It cannot be excluded given the limited under-
standing  of  etiology  and  mechanisms,  whether  this 
replacement would even be triggering risks and harm 
towards an undesired direction� In a recent study, the 
reduction of sugar levels in tobacco by changing cur-
ing conditions and regulating the amount that is added 
was mentioned as a possibility to reduce the formation 
of  carbonyl  compounds  (Talhout  et  al�,  2011)�  These 
authors recognized, though, that any such action may 
result in shifting risks from one group of constituents to 
another, which would actually be the case based on the 
current assessment�
9.  Overall conclusion
In  a  comprehensive  assessment,  the  potential  effects 
of using sugars as ingredients in American-blend ciga-
rettes were evaluated� While some changes with sugar 
application were detected, the overall evaluation of all 
data considered on a weight-of-evidence basis suggests 
that the use of sugars would “add no significant toxicity 
to tobacco products and therefore could be considered 
safe in the context of this use” (stipulation taken from 
the US Institute of Medicine, 2001)� This conclusion is 
based on the results of chemical analytical, in vitro, and 
subchronic  inhalation  studies  with  research  cigarettes 
with and without sugars as tobacco ingredients� In the 
current assessment, the evaluation was extended beyond 
previous assessments to include information on smoke 
exposure and smoking behavior, which was achieved by 
comparing  markets  of  predominantly  American-blend 
or Virginia-type cigarettes� From these comparisons, e�g� 
for nicotine uptake levels, no indication of sugar appli-
cation-related  differences  could  be  derived�  The  data 
analyzed do not support concerns that the use of sugars 
as ingredients would increase tobacco smoking depen-
dence� No difference in mortality due to smoking-related 
diseases  could  be  detected  between  American-blend 
and Virginia-type markets, which could have shed light 
on any population-based harm related to sugar applica-
tion� In conclusion, thorough examination of the data 
available suggests that the use of sugars as ingredients in 
cigarette tobacco does not increase risk or harm beyond 
that inherent to cigarette smoking�
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